[{"command":"settings","settings":{"pluralDelimiter":"\u0003","suppressDeprecationErrors":true,"bpi_euroquity":{"currentGroupId":"11021"},"field_group":{"html_element":{"mode":"stream","context":"view","settings":{"classes":"","show_empty_fields":false,"id":"","element":"div","show_label":true,"label_element":"h6","label_element_classes":"","attributes":"","effect":"none","speed":"fast"}}},"user":{"uid":0,"permissionsHash":"6391a22d424c17c4b9b80a83067a2f59567dfd7ef4ff37706399701c8221e9e7"}},"merge":true},{"command":"add_css","data":[{"rel":"stylesheet","media":"all","href":"\/sites\/euroquity\/files\/css\/css_yQgs0xFYswCWvgYKJHSjY_Jy2vnz311baF1QMHMKgiM.css?delta=0\u0026language=fr\u0026theme=bpi_theme_euroquity\u0026include=eJxLKsiML8lIzU2NTy0tyi8szSyp1E_Ozy3Iz0vNK9FLTizKLy1OzQEAMEQPkg"}]},{"command":"add_js","selector":"body","data":[{"src":"\/core\/assets\/vendor\/jquery\/jquery.min.js?v=3.7.1"},{"src":"https:\/\/dr84voq2lwxr8.cloudfront.net\/s3fs-public\/languages\/fr_Hv0NobP8jWG9vPpaDYDc8LIxZnHS3Hj09ZBbIdRPfoA.js?skq4cr"},{"src":"\/core\/misc\/drupalSettingsLoader.js?v=10.3.2"},{"src":"\/core\/misc\/drupal.js?v=10.3.2"},{"src":"\/core\/misc\/drupal.init.js?v=10.3.2"},{"src":"\/modules\/custom\/bpi_euroquity\/js\/group_admins_ajax.js?v=10.3.2","defer":true},{"src":"\/themes\/custom\/bpi_theme_euroquity\/assets\/libraries\/carousel\/carousel.min.js?v=10.3.2","defer":true},{"src":"\/themes\/custom\/bpi_theme_euroquity\/assets\/js\/carousel.js?v=10.3.2","defer":true}]},{"command":"insert","method":"html","selector":"#lazy-group-content","data":" \n\u003Cdiv class=\u0022grid gap-4 md:gap-6 md:grid-flow-col md:grid-cols-12 mt-6\u0022\u003E\n \u003Cdiv class=\u0022md:col-span-8 md:row-span-3 h-fit space-y-6 min-w-0\u0022\u003E\n \u003Cdiv class=\u0022card\u0022\u003E\n \u003Cdiv class=\u0022banner aspect-w-16 aspect-h-9 md:aspect-h-5 relative\u0022\u003E\n \u003Cpicture\u003E\n \u003Csource srcset=\u0022https:\/\/dr84voq2lwxr8.cloudfront.net\/s3fs-public\/styles\/eqt_presentation_desktop\/public\/legacy\/1820\/acda78b9-gliocure-photo-web-1_0.jpg?VersionId=nQYEkSxJy1elWZY_fRg7_o_NvO2KHWn2\u0026amp;itok=o_xR7zov 1x\u0022 media=\u0022all and (min-width: 1024px)\u0022 type=\u0022image\/jpeg\u0022 width=\u0022848\u0022 height=\u0022477\u0022\/\u003E\n \u003Csource srcset=\u0022https:\/\/dr84voq2lwxr8.cloudfront.net\/s3fs-public\/styles\/eqt_presentation_mobile\/public\/legacy\/1820\/acda78b9-gliocure-photo-web-1_0.jpg?VersionId=8PuECI7sfK3TtjKMYediifa1hAkaaoTo\u0026amp;itok=hi5SYnRK 1x\u0022 media=\u0022all and (max-width: 767px)\u0022 type=\u0022image\/jpeg\u0022 width=\u0022360\u0022 height=\u0022202\u0022\/\u003E\n \u003Cimg loading=\u0022eager\u0022 src=\u0022https:\/\/dr84voq2lwxr8.cloudfront.net\/s3fs-public\/styles\/eqt_presentation_mobile\/public\/legacy\/1820\/acda78b9-gliocure-photo-web-1_0.jpg?VersionId=8PuECI7sfK3TtjKMYediifa1hAkaaoTo\u0026amp;itok=hi5SYnRK\u0022 width=\u0022360\u0022 height=\u0022202\u0022 \/\u003E\n\n \u003C\/picture\u003E\n\n\n \u003C\/div\u003E\n \u003Cdiv class=\u0022bg-brand-light p-4 md:p-8\u0022\u003E\n \u003Cdiv class=\u0022container-show-more-lines break-words\u0022\u003E\n \u003Ch2 class=\u0022h4 text-base mb-2\u0022\u003E\n A propos de votre organisation\n \u003C\/h2\u003E\n \u003Cdiv class=\u0022rich-text content\u0022\u003E\n \u003Cp\u003EGlioCure est n\u00e9e en septembre 2016 de la rencontre entre Jo\u00ebl Eyer, Directeur de Recherche au sein de l\u2019\u00e9quipe INSERM\/CNRS \u00ab Micro et Nanom\u00e9decines Translationnelles \u00bb (MINT) \u00e0 Angers, Claire L\u00e9pinoux-Chambaud, docteur en neurosciences, et Louis-Marie Bachelot, entrepreneur sp\u00e9cialis\u00e9 en th\u00e9rapies innovantes et maladies rares.\u0026nbsp;\u003C\/p\u003E\n\u003Cp\u003ESp\u00e9cialis\u00e9e dans le d\u00e9veloppement de mol\u00e9cules th\u00e9rapeutiques en neuro-oncologie, GlioCure ambitionne de redonner espoir aux patients souffrants de maladies gliales, et notamment aux malades atteints de tumeurs c\u00e9r\u00e9brales.\u003Cbr\u003E Pour relever ce d\u00e9fi, GlioCure a r\u00e9uni un conseil scientifique et m\u00e9dical d\u2019experts internationaux disposant de toutes les comp\u00e9tences n\u00e9cessaires au d\u00e9veloppement translationnel sur ces indications.\u003Cbr\u003E GlioCure offre ainsi une solution unique pour d\u00e9tecter, s\u00e9lectionner et d\u00e9velopper des mol\u00e9cules d\u2019int\u00e9r\u00eat en v\u00e9ritables candidats-m\u00e9dicaments.\u003C\/p\u003E\n\u003Cp\u003ELa premi\u00e8re mol\u00e9cule s\u00e9lectionn\u00e9e et d\u00e9velopp\u00e9e par GlioCure, GC01, est un peptide anti-tumoral et neuroprotecteur de nouvelle g\u00e9n\u00e9ration b\u00e9n\u00e9ficiant de plus de 10 ans de recherche acad\u00e9mique. Elle est couverte par deux familles de brevets, propri\u00e9t\u00e9 des Universit\u00e9s d\u0027Angers (France) et McGill de Montr\u00e9al (Canada), pour lesquels GlioCure dispose des droits exclusifs mondiaux.\u003Cbr\u003E GC01 est actuellement en fin de d\u00e9veloppement pr\u00e9clinique non-r\u00e9glementaire dans le traitement du glioblastome, la tumeur primaire du cerveau la plus fr\u00e9quente et la plus agressive.\u003C\/p\u003E\n\n \u003C\/div\u003E\n \u003Cdiv class=\u0022py-4\u0022\u003E\n \u003Cbutton data-hide-default-content=\u0022false\u0022\n data-long-field=\u0022true\u0022\n data-label-more=\u0022Voir plus\u0022\n data-label-less=\u0022Voir moins\u0022\n aria-expanded=\u0022false\u0022\n type=\u0022button\u0022\n class=\u0022toggle link\u0022\u003E\n Voir plus\n \u003C\/button\u003E\n \u003C\/div\u003E\n \u003C\/div\u003E\n\n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022card\u0022\u003E\n \n\u003Cdiv role=\u0022region\u0022 aria-label=\u0022carousel\u0022\u003E\n \u003Cdiv class=\u0022carousel-covers flex overflow-hidden h-40 md:h-72 relative\u0022\u003E\n \u003Cdiv class=\u0022banner absolute h-full w-full\u0022\u003E\n \u003Cpicture\u003E\n \u003Csource srcset=\u0022https:\/\/dr84voq2lwxr8.cloudfront.net\/s3fs-public\/styles\/eqt_group_news_desktop\/public\/legacy\/1821\/60e4c446-gliocure-curie-2_0.png?VersionId=uLolebVFSU8Ok_uVoHtpmqp05EG5ZIsJ\u0026amp;itok=FN5BTgba 1x\u0022 media=\u0022all and (min-width: 1024px)\u0022 type=\u0022image\/png\u0022 width=\u00221600\u0022 height=\u0022270\u0022\/\u003E\n \u003Csource srcset=\u0022https:\/\/dr84voq2lwxr8.cloudfront.net\/s3fs-public\/styles\/eqt_group_news_medium\/public\/legacy\/1821\/60e4c446-gliocure-curie-2_0.png?VersionId=o3LX3TSALJcg5OoeUnQZLx5NNNLzcwcM\u0026amp;itok=-Cp7OHW4 1x\u0022 media=\u0022all and (min-width: 768px) and (max-width: 1023px)\u0022 type=\u0022image\/png\u0022 width=\u00221024\u0022 height=\u0022270\u0022\/\u003E\n \u003Csource srcset=\u0022https:\/\/dr84voq2lwxr8.cloudfront.net\/s3fs-public\/styles\/eqt_group_news_mobile\/public\/legacy\/1821\/60e4c446-gliocure-curie-2_0.png?VersionId=jJEAV9oCxUFR3zf9wE15jNHGnkumPsqP\u0026amp;itok=0xP5MuPg 1x\u0022 media=\u0022all and (max-width: 767px)\u0022 type=\u0022image\/png\u0022 width=\u0022768\u0022 height=\u0022160\u0022\/\u003E\n \u003Cimg loading=\u0022lazy\u0022 src=\u0022https:\/\/dr84voq2lwxr8.cloudfront.net\/s3fs-public\/styles\/eqt_group_news_mobile\/public\/legacy\/1821\/60e4c446-gliocure-curie-2_0.png?VersionId=jJEAV9oCxUFR3zf9wE15jNHGnkumPsqP\u0026amp;itok=0xP5MuPg\u0022 width=\u0022768\u0022 height=\u0022160\u0022 \/\u003E\n\n \u003C\/picture\u003E\n\n\n \u003C\/div\u003E\n\u003Cdiv class=\u0022banner absolute h-full w-full\u0022\u003E\n \u003Cpicture\u003E\n \u003Csource srcset=\u0022https:\/\/dr84voq2lwxr8.cloudfront.net\/s3fs-public\/styles\/eqt_group_news_desktop\/public\/legacy\/1229\/692a9c37-image-for-your-website-2_0.jpg?VersionId=2YQQcQn3sMoSMrpGHubA3ibWiqgtUcrN\u0026amp;itok=D6TAlxHW 1x\u0022 media=\u0022all and (min-width: 1024px)\u0022 type=\u0022image\/jpeg\u0022 width=\u00221600\u0022 height=\u0022270\u0022\/\u003E\n \u003Csource srcset=\u0022https:\/\/dr84voq2lwxr8.cloudfront.net\/s3fs-public\/styles\/eqt_group_news_medium\/public\/legacy\/1229\/692a9c37-image-for-your-website-2_0.jpg?VersionId=x_RBv3foF3QBGHqdAE24SxxO.BUtWOrA\u0026amp;itok=Ly3R_Vxn 1x\u0022 media=\u0022all and (min-width: 768px) and (max-width: 1023px)\u0022 type=\u0022image\/jpeg\u0022 width=\u00221024\u0022 height=\u0022270\u0022\/\u003E\n \u003Csource srcset=\u0022https:\/\/dr84voq2lwxr8.cloudfront.net\/s3fs-public\/styles\/eqt_group_news_mobile\/public\/legacy\/1229\/692a9c37-image-for-your-website-2_0.jpg?VersionId=7YqhRjQopJOFa3VwoyjbfjkkRJ.kd0IV\u0026amp;itok=SybN6O7X 1x\u0022 media=\u0022all and (max-width: 767px)\u0022 type=\u0022image\/jpeg\u0022 width=\u0022768\u0022 height=\u0022160\u0022\/\u003E\n \u003Cimg loading=\u0022lazy\u0022 src=\u0022https:\/\/dr84voq2lwxr8.cloudfront.net\/s3fs-public\/styles\/eqt_group_news_mobile\/public\/legacy\/1229\/692a9c37-image-for-your-website-2_0.jpg?VersionId=7YqhRjQopJOFa3VwoyjbfjkkRJ.kd0IV\u0026amp;itok=SybN6O7X\u0022 width=\u0022768\u0022 height=\u0022160\u0022 \/\u003E\n\n \u003C\/picture\u003E\n\n\n \u003C\/div\u003E\n\u003Cdiv class=\u0022banner absolute h-full w-full\u0022\u003E\n \u003Cpicture\u003E\n \u003Csource srcset=\u0022https:\/\/dr84voq2lwxr8.cloudfront.net\/s3fs-public\/styles\/eqt_group_news_desktop\/public\/legacy\/1229\/b3240ba9-winners_0.jpg?VersionId=KLsyQJvU7kTY_p89Y4XzoyMtgslvUfU1\u0026amp;itok=V9xaALqk 1x\u0022 media=\u0022all and (min-width: 1024px)\u0022 type=\u0022image\/jpeg\u0022 width=\u00221600\u0022 height=\u0022270\u0022\/\u003E\n \u003Csource srcset=\u0022https:\/\/dr84voq2lwxr8.cloudfront.net\/s3fs-public\/styles\/eqt_group_news_medium\/public\/legacy\/1229\/b3240ba9-winners_0.jpg?VersionId=gR71SM_3MqIgX_IJFH9usISSDIz8Pf_1\u0026amp;itok=u1Hbwact 1x\u0022 media=\u0022all and (min-width: 768px) and (max-width: 1023px)\u0022 type=\u0022image\/jpeg\u0022 width=\u00221024\u0022 height=\u0022270\u0022\/\u003E\n \u003Csource srcset=\u0022https:\/\/dr84voq2lwxr8.cloudfront.net\/s3fs-public\/styles\/eqt_group_news_mobile\/public\/legacy\/1229\/b3240ba9-winners_0.jpg?VersionId=N5THSrlji_cXM763RFgp4oBIOXnuLKdD\u0026amp;itok=0Gp4_kje 1x\u0022 media=\u0022all and (max-width: 767px)\u0022 type=\u0022image\/jpeg\u0022 width=\u0022768\u0022 height=\u0022160\u0022\/\u003E\n \u003Cimg loading=\u0022lazy\u0022 src=\u0022https:\/\/dr84voq2lwxr8.cloudfront.net\/s3fs-public\/styles\/eqt_group_news_mobile\/public\/legacy\/1229\/b3240ba9-winners_0.jpg?VersionId=N5THSrlji_cXM763RFgp4oBIOXnuLKdD\u0026amp;itok=0Gp4_kje\u0022 width=\u0022768\u0022 height=\u0022160\u0022 \/\u003E\n\n \u003C\/picture\u003E\n\n\n \u003C\/div\u003E\n\u003Cdiv class=\u0022banner absolute h-full w-full\u0022\u003E\n \u003Cpicture\u003E\n \u003Csource srcset=\u0022https:\/\/dr84voq2lwxr8.cloudfront.net\/s3fs-public\/styles\/eqt_group_news_desktop\/public\/legacy\/877\/64f9f9eb-challenges_les-100-meilleures-start-up-2018_0.png?VersionId=PjgM0yWXMm3U7QUUPE6V.yZeG76FggWn\u0026amp;itok=6ZhZaoAY 1x\u0022 media=\u0022all and (min-width: 1024px)\u0022 type=\u0022image\/png\u0022 width=\u00221600\u0022 height=\u0022270\u0022\/\u003E\n \u003Csource srcset=\u0022https:\/\/dr84voq2lwxr8.cloudfront.net\/s3fs-public\/styles\/eqt_group_news_medium\/public\/legacy\/877\/64f9f9eb-challenges_les-100-meilleures-start-up-2018_0.png?VersionId=65uUKXZAoC3Vmfh4JwstkzbCqJsTE1DC\u0026amp;itok=1NWDGTCg 1x\u0022 media=\u0022all and (min-width: 768px) and (max-width: 1023px)\u0022 type=\u0022image\/png\u0022 width=\u00221024\u0022 height=\u0022270\u0022\/\u003E\n \u003Csource srcset=\u0022https:\/\/dr84voq2lwxr8.cloudfront.net\/s3fs-public\/styles\/eqt_group_news_mobile\/public\/legacy\/877\/64f9f9eb-challenges_les-100-meilleures-start-up-2018_0.png?VersionId=FYbI5gaJ24E7pXQPg1xWD6l78RSMTQB6\u0026amp;itok=s36SSAZx 1x\u0022 media=\u0022all and (max-width: 767px)\u0022 type=\u0022image\/png\u0022 width=\u0022768\u0022 height=\u0022160\u0022\/\u003E\n \u003Cimg loading=\u0022lazy\u0022 src=\u0022https:\/\/dr84voq2lwxr8.cloudfront.net\/s3fs-public\/styles\/eqt_group_news_mobile\/public\/legacy\/877\/64f9f9eb-challenges_les-100-meilleures-start-up-2018_0.png?VersionId=FYbI5gaJ24E7pXQPg1xWD6l78RSMTQB6\u0026amp;itok=s36SSAZx\u0022 width=\u0022768\u0022 height=\u0022160\u0022 \/\u003E\n\n \u003C\/picture\u003E\n\n\n \u003C\/div\u003E\n\u003Cdiv class=\u0022banner absolute h-full w-full\u0022\u003E\n \u003Cpicture\u003E\n \u003Csource srcset=\u0022https:\/\/dr84voq2lwxr8.cloudfront.net\/s3fs-public\/styles\/eqt_group_news_desktop\/public\/legacy\/576\/0d3f72ee-biotechfinances_matwin_20170327_0.jpeg?VersionId=ZEygzQoO1umuCqNaSs4zng2NC0X8V.hl\u0026amp;itok=5UkYdPSK 1x\u0022 media=\u0022all and (min-width: 1024px)\u0022 type=\u0022image\/jpeg\u0022 width=\u00221600\u0022 height=\u0022270\u0022\/\u003E\n \u003Csource srcset=\u0022https:\/\/dr84voq2lwxr8.cloudfront.net\/s3fs-public\/styles\/eqt_group_news_medium\/public\/legacy\/576\/0d3f72ee-biotechfinances_matwin_20170327_0.jpeg?VersionId=P.jBPTDP.H_ccd1erAhgDH1zQRDI5yZ6\u0026amp;itok=CNWi9pM- 1x\u0022 media=\u0022all and (min-width: 768px) and (max-width: 1023px)\u0022 type=\u0022image\/jpeg\u0022 width=\u00221024\u0022 height=\u0022270\u0022\/\u003E\n \u003Csource srcset=\u0022https:\/\/dr84voq2lwxr8.cloudfront.net\/s3fs-public\/styles\/eqt_group_news_mobile\/public\/legacy\/576\/0d3f72ee-biotechfinances_matwin_20170327_0.jpeg?VersionId=STaSR5TrGK2PZMfHO1r6t7mDLXiU3fyy\u0026amp;itok=AAmufKsw 1x\u0022 media=\u0022all and (max-width: 767px)\u0022 type=\u0022image\/jpeg\u0022 width=\u0022768\u0022 height=\u0022160\u0022\/\u003E\n \u003Cimg loading=\u0022lazy\u0022 src=\u0022https:\/\/dr84voq2lwxr8.cloudfront.net\/s3fs-public\/styles\/eqt_group_news_mobile\/public\/legacy\/576\/0d3f72ee-biotechfinances_matwin_20170327_0.jpeg?VersionId=STaSR5TrGK2PZMfHO1r6t7mDLXiU3fyy\u0026amp;itok=AAmufKsw\u0022 width=\u0022768\u0022 height=\u0022160\u0022 \/\u003E\n\n \u003C\/picture\u003E\n\n\n \u003C\/div\u003E\n\n \n \u003C\/div\u003E\n \u003Cdiv class=\u0022py-4 md:py-8\u0022\u003E\n \u003Cheader class=\u0022flex items-center mb-2 md:mb-4 px-4 md:px-8\u0022\u003E\n \u003Ch2 class=\u0022h5 flex-1 text-content-light\u0022\u003E\n Actualit\u00e9s\n \u003C\/h2\u003E\n \u003Cdiv class=\u0022flex items-center justify-center space-x-2\u0022 aria-label=\u0022gallery controls\u0022\u003E\n \u003Cbutton class=\u0022carousel-arrow\u0022 aria-label=\u0022Previous\u0022\u003E\n \u003Cspan class=\u0022sr-only\u0022\u003EPrevious\u003C\/span\u003E\n \u003Csvg class=\u0022h-5 w-5\u0022\n xmlns=\u0022http:\/\/www.w3.org\/2000\/svg\u0022\n viewBox=\u00220 0 20 20\u0022\n fill=\u0022currentColor\u0022\n aria-hidden=\u0022true\u0022\u003E\n \u003Cpath fill-rule=\u0022evenodd\u0022\n d=\u0022M12.707 5.293a1 1 0 010 1.414L9.414 10l3.293 3.293a1 1 0 01-1.414 1.414l-4-4a1 1 0 010-1.414l4-4a1 1 0 011.414 0z\u0022\n clip-rule=\u0022evenodd\u0022 \/\u003E\n \u003C\/svg\u003E\n \u003C\/button\u003E\n\n \u003Cdiv class=\u0022carousel-pagination\u0022 aria-live=\u0022polite\u0022 aria-atomic=\u0022true\u0022\u003E\n \u003Cspan data-eq-carousel-current-page=\u00221\u0022\u003E\u003C\/span\u003E\/5\n \u003C\/div\u003E\n \n \u003Cbutton class=\u0022carousel-arrow\u0022 aria-label=\u0022Next\u0022\u003E\n \u003Cspan class=\u0022sr-only\u0022\u003ENext\u003C\/span\u003E\n \u003Csvg class=\u0022h-5 w-5\u0022\n xmlns=\u0022http:\/\/www.w3.org\/2000\/svg\u0022\n viewBox=\u00220 0 20 20\u0022\n fill=\u0022currentColor\u0022\n aria-hidden=\u0022true\u0022\u003E\n \u003Cpath fill-rule=\u0022evenodd\u0022\n d=\u0022M7.293 14.707a1 1 0 010-1.414L10.586 10 7.293 6.707a1 1 0 011.414-1.414l4 4a1 1 0 010 1.414l-4 4a1 1 0 01-1.414 0z\u0022\n clip-rule=\u0022evenodd\u0022 \/\u003E\n \u003C\/svg\u003E\n \u003C\/button\u003E\n \u003C\/div\u003E\n \u003C\/header\u003E\n \u003Cdiv class=\u0022carousel-wrapper\u0022\n data-eq-carousel-items-to-display=\u00221\u0022\u003E\n \u003Carticle class=\u0022carousel-item container-show-more-lines w-full px-4 md:px-8\u0022 role=\u0022group\u0022\u003E\n \u003Cheader class=\u0022space-y-4\u0022\u003E\n \u003Cdiv class=\u0022flex items-center\u0022\u003E\n \u003Cdiv class=\u0022flex-shrink-0 h-10 w-10 max-w-full\u0022\u003E\n \u003Cdiv class=\u0022profile profile--44593 profile--type--profile profile--is-default profile--view-mode--picture clearfix\u0022\u003E\n \n \u003Cimg loading=\u0022lazy\u0022 src=\u0022https:\/\/dr84voq2lwxr8.cloudfront.net\/s3fs-public\/styles\/social_medium\/public\/legacy\/485\/ace651d4-photo-reseaux-sociaux_0.jpg?VersionId=VjaAqehDeVD8Sa2OVWWkbYQGqlLeLcms\u0026amp;itok=oILBrWuF\u0022 width=\u002244\u0022 height=\u002244\u0022 alt=\u0022Profile photo\u0022 class=\u0022image-style-social-medium\u0022 \/\u003E\n\n\n\n\n\u003C\/div\u003E\n\n \u003C\/div\u003E\n \u003Cdiv class=\u0022ml-4 flex-1\u0022\u003E\n \u003Cdiv class=\u0022text-sm\u0022\u003E\n \u003Ca href=\u0022\/fr\/profile\/44593\u0022 class=\u0022font-bold link\u0022\u003ELouis-Marie Bachelot\u003C\/a\u003E\n \u003Cspan\u003E(CEO,\u003C\/span\u003E\n \u003Ca href=\u0022\/fr\/societe\/gliocure\u0022 class=\u0022font-medium link\u0022\u003E\n GlioCure\n \u003C\/a\u003E)\n \u003C\/div\u003E\n \u003Cp class=\u0022text-sm\u0022\u003E\n Publi\u00e9 il y a 3 ans \n \u003C\/p\u003E\n \u003C\/div\u003E\n \u003C\/div\u003E\n\n \u003Ch3 class=\u0022rich-text article\u0022\u003E\n \u003Ca href=\u0022\/fr\/node\/3870\u0022 data-post-title=\u0022GlioCure et l\u2019Institut Curie initient une collaboration de recherche avec le soutien de FINDMED\u0022 data-post-orga-uuid=4d5abf7d-bdd7-493f-bb1b-dcbbdbb1209a\u003E\n \n\u003Cspan\u003EGlioCure et l\u2019Institut Curie initient une collaboration de recherche avec le soutien de FINDMED\u003C\/span\u003E\n\n \u003C\/a\u003E\n \u003C\/h3\u003E\n \u003C\/header\u003E\n \u003Cdiv class=\u0022rich-text content\u0022\u003E\n \u003Cp\u003E\u003Cstrong\u003EAngers, Paris \u2013\u003C\/strong\u003E \u003Cstrong\u003EGlioCure SAS, soci\u00e9t\u00e9 de biotechnologie sp\u00e9cialis\u00e9e en neuro-oncologie, et l\u2019Institut Curie \/ Carnot Curie Cancer, annoncent le lancement d\u2019un projet de recherche collaboratif avec le soutien de FINDMED, l\u2019une des huit actions Carnot fili\u00e8res, dans le cadre du programme CHICHE ! Objectif\u0026nbsp;? \u00c9valuer l\u2019efficacit\u00e9 du candidat-m\u00e9dicament de GlioCure dans des mod\u00e8les PDX, pour le d\u00e9veloppement de nouvelles th\u00e9rapies en canc\u00e9rologie\u003C\/strong\u003E.\u003C\/p\u003E\n\u003Cp\u003EGC01, candidat-m\u00e9dicament le plus avanc\u00e9 de GlioCure, est un peptide anti-tumoral qui a d\u00e9j\u00e0 fait la preuve de son efficacit\u00e9 in vivo sur des mod\u00e8les de glioblastome, la tumeur du cerveau la plus fr\u00e9quente et la plus agressive. GC01 agit en bloquant la division cellulaire de mani\u00e8re sp\u00e9cifique via l\u2019inhibition de la polym\u00e9risation de TUBB3, une mol\u00e9cule constitutive des microtubules, surexprim\u00e9e dans la plupart des tumeurs c\u00e9r\u00e9brales mais \u00e9galement, de mani\u00e8re variable, dans d\u2019autres cancers solides.\u003C\/p\u003E\n\u003Cp\u003EL\u2019\u00e9quipe du Laboratoire d\u2019Investigation Pr\u00e9clinique de l\u2019Institut Curie \/ Carnot Curie Cancer, qui dispose d\u2019environ 300 x\u00e9nogreffes de tumeurs d\u00e9riv\u00e9es de patients (PDX), va ainsi \u00e9valuer l\u2019activit\u00e9 anti-tumorale de GC01 in vivo, seul et en combinaison, sur trois panels de PDX du cancer du sein, de l\u2019ovaire et du poumon non \u00e0 petites cellules sur-exprimant la TUBB3.\u003C\/p\u003E\n\u003Cp\u003EA terme, cette collaboration vise \u00e0 d\u00e9velopper de nouveaux traitements contre les cancers solides, repr\u00e9sentant aujourd\u2019hui 90% des cancers humains.\u003C\/p\u003E\n\u003Cp\u003E\u00ab\u0026nbsp;\u003Cem\u003ECe projet d\u2019une dur\u00e9e d\u2019un an repr\u00e9sente un effort total d\u2019environ 200.000 \u20ac dont le premier quart sera couvert par le programme \u003C\/em\u003E\u003Cstrong\u003E\u003Cem\u003ECHICHE\u003C\/em\u003E\u003C\/strong\u003E\u003Cem\u003E\u0026nbsp;(CHallengez les Instituts Carnot en cHimie et santE) ! Le programme port\u00e9 par la fili\u00e8re FINDMED a \u00e9t\u00e9 un levier essentiel pour permettre d\u2019initier ce partenariat ambitieux entre GlioCure et les \u00e9quipes de l\u2019Institut Curie \/ Carnot Curie Cancer\u0026nbsp;\u003C\/em\u003E\u00bb, indique \u003Cstrong\u003EAmaury Martin, PhD, Directeur Valorisation et Partenariats Industriels \u00e0 l\u2019Institut Curie et Directeur du Carnot Curie Cancer.\u003C\/strong\u003E\u003C\/p\u003E\n\u003Cp\u003E\u003Cstrong\u003ELouis-Marie Bachelot, Pr\u00e9sident co-fondateur de GlioCure \u003C\/strong\u003Eajoute\u0026nbsp;: \u003Cem\u003E\u00ab Nous sommes ravis de pouvoir initier cette collaboration avec le laboratoire du Dr Decaudin au sein de cette prestigieuse maison qu\u2019est l\u2019Institut Curie. L\u2019expertise du LIP en mati\u00e8re de x\u00e9nogreffes de tumeurs d\u00e9riv\u00e9es de patients est reconnue internationalement ; et l\u2019excellente connaissance des peptides th\u00e9rapeutiques du Dr. Decaudin est un pr\u00e9cieux atout suppl\u00e9mentaire. Nous remercions vivement le consortium FINDMED sans le soutien duquel cette collaboration n\u2019aurait certainement pas eu la m\u00eame dimension. \u00bb\u003C\/em\u003E\u003C\/p\u003E\n\u003Cp\u003E\u003Cem\u003E\u00ab GC01 a montr\u00e9 des r\u00e9sultats prometteurs dans le traitement des glioblastomes dont le pronostic est aujourd\u2019hui r\u00e9serv\u00e9. Aussi, la perspective d\u2019une forte activit\u00e9 anti-tumorale du compos\u00e9 sur des tumeurs solides exprimant la cible th\u00e9rapeutique, coupl\u00e9e \u00e0 l\u2019\u00e9tude de son efficacit\u00e9 en association avec des traitements standards, r\u00e9pond pleinement au double objectif du Laboratoire d\u2019Investigation Pr\u00e9clinique de l\u2019Institut Curie, \u00e0 savoir proposer des mod\u00e8les pertinents pour la s\u00e9lection des traitements innovants, et participer au processus g\u00e9n\u00e9ral du d\u00e9veloppement des nouvelles th\u00e9rapies en canc\u00e9rologie \u00bb\u003C\/em\u003E, d\u00e9clare le \u003Cstrong\u003EDr Didier Decaudin, Responsable du Laboratoire d\u2019Investigation Pr\u00e9clinique de l\u2019Institut Curie.\u003C\/strong\u003E\u003C\/p\u003E\n\u003Cp\u003E\u003Cem\u003E\u00ab FINDMED est l\u00e0 dans sa mission consistant \u00e0 aider les TPE, PME et ETI, \u00e0 pouvoir acc\u00e9der aux expertises des Instituts Carnot, et je suis ravi que FINDMED ait pu financer la partie initiale et pr\u00e9paratoire des travaux sur les mod\u00e8les, sans les r\u00e9sultats de laquelle GlioCure n\u2019aurait pas pu s\u2019engager \u00bb\u003C\/em\u003E ajoute \u003Cstrong\u003EDamien Salauze, Directeur des Op\u00e9rations, FINDMED\u003C\/strong\u003E.\u003C\/p\u003E\n\u003Cp\u003E\u0026nbsp;\u003C\/p\u003E\n\u003Cp\u003E\u003Cstrong\u003EContacts Presse et M\u00e9dia :\u003C\/strong\u003E\u003Cbr\u003E\u003Cbr\u003E\nInstitut Curie : Elsa Champion - +33 (0)7 64 43 09 28 - \u003Cem\u003E\u003Ca href=\u0022mailto:elsa.champion@curie.fr\u0022\u003Eelsa.champion@curie.fr\u003C\/a\u003E\u003C\/em\u003E\u003Cbr\u003E\u003Cbr\u003E\nGlioCure : Louis-Marie Bachelot -\u0026nbsp;+33 (0)6 14 03 38 26\u0026nbsp;-\u003Ca href=\u0022mailto:lm.bachelot@gliocure.com\u0022\u003E\u0026nbsp;\u003Cu\u003E\u003Cem\u003Elm.bachelot@gliocure.com\u003C\/em\u003E\u003C\/u\u003E\u003C\/a\u003E\u003C\/p\u003E\n\u003Cp\u003E\u003Cstrong\u003EA propos de GlioCure\u0026nbsp;:\u003C\/strong\u003E\u003Cbr\u003E\u003Cbr\u003E\nGlioCure est une spin-off des universit\u00e9s d\u2019Angers et McGill Montr\u00e9al sp\u00e9cialis\u00e9e en neuro-oncologie.\u003Cbr\u003E\u003Cbr\u003E\nPositionn\u00e9e sur le champ des maladies affectant les cellules gliales, cellules essentielles au bon fonctionnement des neurones et du cerveau, GlioCure s\u0027attache \u00e0 identifier, s\u00e9lectionner et d\u00e9velopper de nouvelles mol\u00e9cules d\u0027int\u00e9r\u00eat notamment pour le traitement des tumeurs c\u00e9r\u00e9brales.\u003Cbr\u003E\u003Cbr\u003E\nGlioCure a ainsi initi\u00e9 le d\u00e9veloppement d\u2019un premier actif, GC01, un peptide antimitotique et neuro-protecteur \u00ab\u0026nbsp;first-in-class\u0026nbsp;\u00bb, dans le traitement du glioblastome, la tumeur du cerveau la plus fr\u00e9quente et la plus agressive avec une survie m\u00e9diane de 15 \u00e0 18 mois apr\u00e8s diagnostic et environ 200.000 d\u00e9c\u00e8s par an dans le monde.\u003Cbr\u003E\u003Cbr\u003E\nPour en savoir plus :\u0026nbsp;\u003Cstrong\u003E\u003Ca href=\u0022https:\/\/www.gliocure.com\/\u0022\u003Egliocure.com\u003C\/a\u003E\u003C\/strong\u003E\u003C\/p\u003E\n\u003Cp\u003E\u003Cstrong\u003EA\u0300 \u003C\/strong\u003E\u003Cstrong\u003Epropos de l\u2019Institut Curie:\u003C\/strong\u003E\u003Cbr\u003E\u003Cbr\u003E\nL\u2019Institut Curie, 1er centre fran\u00e7ais de lutte contre le cancer, associe un centre de recherche de renomm\u00e9e internationale et un ensemble hospitalier de pointe qui prend en charge tous les cancers y compris les plus rares. Fond\u00e9 en 1909 par Marie Curie, l\u2019Institut Curie rassemble sur 3 sites (Paris, Saint-Cloud et Orsay) plus de 3 500 chercheurs, m\u00e9decins et soignants autour de ses 3 missions : soins, recherche et enseignement. Fondation priv\u00e9e reconnue d\u2019utilit\u00e9 publique habilit\u00e9e \u00e0 recevoir des dons et des legs, l\u2019Institut Curie peut, gr\u00e2ce au soutien de ses donateurs, acc\u00e9l\u00e9rer les d\u00e9couvertes et ainsi am\u00e9liorer les traitements et la qualit\u00e9 de vie des malades.\u003Cbr\u003E\u003Cbr\u003E\nPour en savoir plus : \u003Ca href=\u0022https:\/\/curie.fr\/\u0022\u003E\u003Cstrong\u003Ecurie.fr\u003C\/strong\u003E\u003C\/a\u003E\u003C\/p\u003E\n\u003Cp\u003E\u003Cstrong\u003EA\u0300 \u003C\/strong\u003E\u003Cstrong\u003Epropos de FINDMED :\u003C\/strong\u003E\u003Cbr\u003E\u003Cbr\u003E\nFINDMED, un projet au plus pr\u00e8s des entreprises. Ce sont seize instituts Carnot, acteurs majeurs de la recherche publique et de la sant\u00e9 qui se sont regroup\u00e9s dans l\u2019action Carnot fili\u00e8res FINDMED pour faciliter l\u2019acc\u00e8s \u00e0 leurs plateformes technologiques et \u00e0 leurs capacit\u00e9s d\u2019innovation, aux TPE, PME et ETI du secteur de l\u2019industrie du m\u00e9dicament. Leur objectif commun : renforcer la comp\u00e9titivit\u00e9 de ces entreprises en accompagnant leur d\u00e9veloppement.\u003Cbr\u003E\u003Cbr\u003E\nFINDMED est l\u2019une des huit actions Carnot fili\u00e8res, port\u00e9es par l\u2019Etat dans le cadre du Programme Investissements d\u2019Avenir. Elle regroupe seize acteurs majeurs de la recherche et de l\u2019innovation, les instituts Carnot ICM, Curie-Cancer, Voir et Entendre, CALYM, Pasteur MS, France Futur \u00c9levage, Qualiment, CEA-List, Smiles, I2C, Imagine, Interfaces, M.I.N.E.S, Chimie Balard Cirimat, MICA et IPGG microfluidique. Le consortium est coordonn\u00e9 par l\u2019institut Carnot ICM.\u003Cbr\u003E\u003Cbr\u003E\nPour en savoir plus : \u003Ca href=\u0022https:\/\/findmed.fr\/\u0022\u003E\u003Cstrong\u003Efindmed.fr\u003C\/strong\u003E\u003C\/a\u003E\u003Cbr\u003E\u003Cbr\u003E\n\u003Cbr\u003E\u003Cbr\u003E\n\u003Cstrong\u003EA\u0300 \u003C\/strong\u003E\u003Cstrong\u003Epropos de Institut Carnot Curie Cancer :\u003C\/strong\u003E\u003Cbr\u003E\u003Cbr\u003E\nDepuis 2011, l\u0027Institut Curie est lab\u00e9lis\u00e9 \u0022 Carnot Curie Cancer\u0022. Le label Carnot est un label d\u0027excellence accord\u00e9 aux structures de recherche acad\u00e9mique dont la qualit\u00e9 et l\u0027implication dans la recherche partenariale sont av\u00e9r\u00e9es. Curie Cancer offre aux partenaires industriels la possibilit\u00e9 de mettre en place des collaborations de recherche, en b\u00e9n\u00e9ficiant de l\u0027expertise des \u00e9quipes de l\u0027Institut Curie, pour le d\u00e9veloppement de solutions th\u00e9rapeutiques innovantes contre les cancers, de la cible th\u00e9rapeutique \u00e0 la validation clinique.\u003Cbr\u003E\u003Cbr\u003E\nPour en savoir plus : \u003Cstrong\u003E\u003Ca href=\u0022http:\/\/www.instituts-carnot.eu\/fr\/institut-carnot\/curie-cancer\u0022\u003Einstituts-carnot.eu\/fr\/institut-carnot\/curie-cancer\u003C\/a\u003E\u003C\/strong\u003E\u003C\/p\u003E\n\n\n \u003C\/div\u003E\n \u003Cdiv class=\u0022py-4\u0022\u003E\n \u003Cbutton data-hide-default-content=\u0022false\u0022\n data-label-more=\u0022Voir plus\u0022\n data-label-less=\u0022Voir moins\u0022\n aria-expanded=\u0022false\u0022\n type=\u0022button\u0022\n class=\u0022toggle link\u0022\u003E\n Voir plus\n \u003C\/button\u003E\n \u003C\/div\u003E\n\u003C\/article\u003E\n\u003Carticle class=\u0022carousel-item container-show-more-lines w-full px-4 md:px-8\u0022 role=\u0022group\u0022\u003E\n \u003Cheader class=\u0022space-y-4\u0022\u003E\n \u003Cdiv class=\u0022flex items-center\u0022\u003E\n \u003Cdiv class=\u0022flex-shrink-0 h-10 w-10 max-w-full\u0022\u003E\n \u003Cdiv class=\u0022profile profile--44593 profile--type--profile profile--is-default profile--view-mode--picture clearfix\u0022\u003E\n \n \u003Cimg loading=\u0022lazy\u0022 src=\u0022https:\/\/dr84voq2lwxr8.cloudfront.net\/s3fs-public\/styles\/social_medium\/public\/legacy\/485\/ace651d4-photo-reseaux-sociaux_0.jpg?VersionId=VjaAqehDeVD8Sa2OVWWkbYQGqlLeLcms\u0026amp;itok=oILBrWuF\u0022 width=\u002244\u0022 height=\u002244\u0022 alt=\u0022Profile photo\u0022 class=\u0022image-style-social-medium\u0022 \/\u003E\n\n\n\n\n\u003C\/div\u003E\n\n \u003C\/div\u003E\n \u003Cdiv class=\u0022ml-4 flex-1\u0022\u003E\n \u003Cdiv class=\u0022text-sm\u0022\u003E\n \u003Ca href=\u0022\/fr\/profile\/44593\u0022 class=\u0022font-bold link\u0022\u003ELouis-Marie Bachelot\u003C\/a\u003E\n \u003Cspan\u003E(CEO,\u003C\/span\u003E\n \u003Ca href=\u0022\/fr\/societe\/gliocure\u0022 class=\u0022font-medium link\u0022\u003E\n GlioCure\n \u003C\/a\u003E)\n \u003C\/div\u003E\n \u003Cp class=\u0022text-sm\u0022\u003E\n Publi\u00e9 il y a 5 ans \n \u003C\/p\u003E\n \u003C\/div\u003E\n \u003C\/div\u003E\n\n \u003Ch3 class=\u0022rich-text article\u0022\u003E\n \u003Ca href=\u0022\/fr\/node\/3374\u0022 data-post-title=\u0022GlioCure re\u00e7oit le \u0026quot;Label d\u0026#039;Excellence\u0026quot; de la Commission Europ\u00e9enne\u0022 data-post-orga-uuid=4d5abf7d-bdd7-493f-bb1b-dcbbdbb1209a\u003E\n \n\u003Cspan\u003EGlioCure re\u00e7oit le \u0026quot;Label d\u0026#039;Excellence\u0026quot; de la Commission Europ\u00e9enne\u003C\/span\u003E\n\n \u003C\/a\u003E\n \u003C\/h3\u003E\n \u003C\/header\u003E\n \u003Cdiv class=\u0022rich-text content\u0022\u003E\n \u003Cp\u003EPARIS 21 juin 2019 - GlioCure s\u0027est vue d\u00e9livr\u00e9e le \u0022Label d\u0027Excellence\u0022 dans le cadre du dispositif H2020 Instrument PME phase 1 pour son projet \u0022Peptide antimitotique changeant la donne pour le traitement du\u0026nbsp;glioblastome et d\u0027autres cancers agressifs surexprimant la \u03b2III-tubuline\u0022.\u003C\/p\u003E\n\u003Cp\u003ELe projet a en effet \u00e9t\u00e9 \u00e9valu\u00e9 par un panel d\u0027experts internationaux qui lui a attribu\u00e9 une note sup\u00e9rieure au seuil d\u0027excellence de 13\/15 pour les trois crit\u00e8res d\u0027excellence scientifique, d\u0027impact et de qualit\u00e9 et efficience de l\u0027impl\u00e9mentation.\u003C\/p\u003E\n\n\n \u003C\/div\u003E\n \u003Cdiv class=\u0022py-4\u0022\u003E\n \u003Cbutton data-hide-default-content=\u0022false\u0022\n data-label-more=\u0022Voir plus\u0022\n data-label-less=\u0022Voir moins\u0022\n aria-expanded=\u0022false\u0022\n type=\u0022button\u0022\n class=\u0022toggle link\u0022\u003E\n Voir plus\n \u003C\/button\u003E\n \u003C\/div\u003E\n\u003C\/article\u003E\n\u003Carticle class=\u0022carousel-item container-show-more-lines w-full px-4 md:px-8\u0022 role=\u0022group\u0022\u003E\n \u003Cheader class=\u0022space-y-4\u0022\u003E\n \u003Cdiv class=\u0022flex items-center\u0022\u003E\n \u003Cdiv class=\u0022flex-shrink-0 h-10 w-10 max-w-full\u0022\u003E\n \u003Cdiv class=\u0022profile profile--44593 profile--type--profile profile--is-default profile--view-mode--picture clearfix\u0022\u003E\n \n \u003Cimg loading=\u0022lazy\u0022 src=\u0022https:\/\/dr84voq2lwxr8.cloudfront.net\/s3fs-public\/styles\/social_medium\/public\/legacy\/485\/ace651d4-photo-reseaux-sociaux_0.jpg?VersionId=VjaAqehDeVD8Sa2OVWWkbYQGqlLeLcms\u0026amp;itok=oILBrWuF\u0022 width=\u002244\u0022 height=\u002244\u0022 alt=\u0022Profile photo\u0022 class=\u0022image-style-social-medium\u0022 \/\u003E\n\n\n\n\n\u003C\/div\u003E\n\n \u003C\/div\u003E\n \u003Cdiv class=\u0022ml-4 flex-1\u0022\u003E\n \u003Cdiv class=\u0022text-sm\u0022\u003E\n \u003Ca href=\u0022\/fr\/profile\/44593\u0022 class=\u0022font-bold link\u0022\u003ELouis-Marie Bachelot\u003C\/a\u003E\n \u003Cspan\u003E(CEO,\u003C\/span\u003E\n \u003Ca href=\u0022\/fr\/societe\/gliocure\u0022 class=\u0022font-medium link\u0022\u003E\n GlioCure\n \u003C\/a\u003E)\n \u003C\/div\u003E\n \u003Cp class=\u0022text-sm\u0022\u003E\n Publi\u00e9 il y a 5 ans \n \u003C\/p\u003E\n \u003C\/div\u003E\n \u003C\/div\u003E\n\n \u003Ch3 class=\u0022rich-text article\u0022\u003E\n \u003Ca href=\u0022\/fr\/node\/3373\u0022 data-post-title=\u0022GlioCure vainqueur de la 5\u00e8me \u00e9dition du Advance Biotech Grant du groupe MERCK\u0022 data-post-orga-uuid=4d5abf7d-bdd7-493f-bb1b-dcbbdbb1209a\u003E\n \n\u003Cspan\u003EGlioCure vainqueur de la 5\u00e8me \u00e9dition du Advance Biotech Grant du groupe MERCK\u003C\/span\u003E\n\n \u003C\/a\u003E\n \u003C\/h3\u003E\n \u003C\/header\u003E\n \u003Cdiv class=\u0022rich-text content\u0022\u003E\n \u003Cp\u003E05\u0026nbsp;F\u00c9VR 2019\u0026nbsp;|\u0026nbsp;MOLSHEIM, FRANCE\u003C\/p\u003E\n\u003Cp\u003EMerck, le groupe de sciences et technologies de pointe, a annonc\u00e9 aujourd\u2019hui les laur\u00e9ats europ\u00e9ens du programme\u0026nbsp;\u003Ca href=\u0022https:\/\/www.merckmillipore.com\/DE\/en\/20170228_004754?ReferrerURL=https%3A%2F%2Fwww.google.com%2F\u0022\u003EAdvance Biotech Grant\u003C\/a\u003E, destin\u00e9 \u00e0 soutenir des petites et moyennes biotech qui ont besoin de fonds et d\u2019expertise pour mettre leurs m\u00e9dicaments sur le march\u00e9.\u003C\/p\u003E\n\u003Cp\u003ELes candidats \u00e0 ce programme devaient pr\u00e9senter leur projet, les besoins m\u00e9dicaux auxquels ils r\u00e9pondent, et les probl\u00e8mes de d\u00e9veloppement de proc\u00e9d\u00e9s de fabrication qu\u2019ils rencontrent.\u003C\/p\u003E\n\u003Cp\u003ETrois startup ont \u00e9t\u00e9 retenues comptant parmi elles 2 soci\u00e9t\u00e9s fran\u00e7aises. Elles percevront chacune une dotation comprise entre 50 000 et 100 000 euros de produits et services Merck.\u003C\/p\u003E\n\u003Cp\u003ELes trois b\u00e9n\u00e9ficiaires, dont deux soci\u00e9t\u00e9s fran\u00e7aises sont\u0026nbsp;:\u003C\/p\u003E\n\u003Cp\u003E\u00b7\u0026nbsp;\u0026nbsp;\u0026nbsp;\u0026nbsp;\u0026nbsp;\u0026nbsp;\u0026nbsp;\u0026nbsp;\u0026nbsp;\u003Cstrong\u003E\u003Ca href=\u0022https:\/\/www.genosciencepharma.com\/\u0022\u003EGenoScience Pharma\u003C\/a\u003E\u0026nbsp;(Marseille, France)\u0026nbsp;\u003C\/strong\u003Epour le d\u00e9veloppement de nouvelles mol\u00e9cules telles que le GNS561, au m\u00e9canisme d\u2019action jamais utilis\u00e9 jusqu\u2019ici dans les traitements du cancer d\u00e9j\u00e0 commercialis\u00e9s et les m\u00e9dicaments anticanc\u00e9reux en cours de d\u00e9veloppement.\u003C\/p\u003E\n\u003Cp\u003E\u00b7\u0026nbsp;\u0026nbsp;\u0026nbsp;\u0026nbsp;\u0026nbsp;\u0026nbsp;\u0026nbsp;\u0026nbsp;\u0026nbsp;\u003Cstrong\u003E\u003Ca href=\u0022http:\/\/www.gliocure.com\/\u0022\u003EGlioCure\u003C\/a\u003E\u0026nbsp;(Angers, France)\u003C\/strong\u003E\u003Cstrong\u003E\u0026nbsp;pour le d\u00e9veloppement du GC01, un peptide anti-tumoral et neuroprotecteur destin\u00e9 au traitement du glioblastome, la tumeur du cerveau la plus fr\u00e9quente et la plus agressive.\u003C\/strong\u003E\u003C\/p\u003E\n\u003Cp\u003E\u00b7\u0026nbsp;\u0026nbsp;\u0026nbsp;\u0026nbsp;\u0026nbsp;\u0026nbsp;\u0026nbsp;\u0026nbsp;\u0026nbsp;\u003Cstrong\u003EResoTher Pharma (Danemark),\u003C\/strong\u003E\u0026nbsp;pour le d\u00e9veloppement de nouveaux m\u00e9dicaments traitants les troubles cardiovasculaires et inflammatoires.\u003C\/p\u003E\n\u003Cp\u003E\u003Cem\u003E\u00ab\u0026nbsp;Depuis des d\u00e9cennies, les experts en d\u00e9veloppement de proc\u00e9d\u00e9s et en fabrication de Merck collaborent avec des laboratoires pharmaceutiques de toute taille afin de les aider \u00e0 surmonter les obstacles qu\u2019ils rencontrent et \u00e0 commercialiser plus rapidement leurs m\u00e9dicaments \u00bb,\u003C\/em\u003E\u0026nbsp;souligne Udit Batra, membre du Conseil de direction et PDG de la division Sciences de la vie de Merck. \u00ab\u0026nbsp;\u003Cem\u003ENotre programme Advance Biotech Grant nous permet d\u2019aider les entrepreneurs du monde entier \u00e0 acc\u00e9l\u00e9rer la mise sur le march\u00e9 de leurs mol\u00e9cules\u0026nbsp;\u00bb.\u003C\/em\u003E\u003C\/p\u003E\n\u003Cp\u003E\u003Cstrong\u003EPremier produit de GlioCure, le GC01 est actuellement en fin de d\u00e9veloppement pr\u00e9clinique non-r\u00e9glementaire dans le traitement du glioblastome, qui repr\u00e9sente environ 15% de l\u2019ensemble des tumeurs c\u00e9r\u00e9brales primaires.\u003C\/strong\u003E\u003C\/p\u003E\n\u003Cp\u003E\u003Cstrong\u003E\u003Cem\u003E\u00ab\u0026nbsp;Nous sommes en train de travailler sur deux formulations diff\u00e9rentes ciblant les tumeurs r\u00e9s\u00e9cables et non r\u00e9s\u00e9cables\u0026nbsp;\u00bb\u003C\/em\u003E\u0026nbsp;pr\u00e9cise Louis-Marie Bachelot, PDG et fondateur de GlioCure.\u0026nbsp;\u003Ca\u003E\u003C\/a\u003E\u003Cem\u003E\u00ab\u0026nbsp;Le programme Advance Biotech Grant ainsi que l\u2019expertise et les capacit\u00e9s de Merck permettront certainement au produit d\u2019atteindre plus rapidement l\u2019\u00e9tape des essais cliniques.\u0026nbsp;\u00bb.\u003C\/em\u003E\u003C\/strong\u003E\u003C\/p\u003E\n\u003Cp\u003EMerck a s\u00e9lectionn\u00e9 les laur\u00e9ats sur la base de plusieurs crit\u00e8res\u0026nbsp;: m\u00e9rite scientifique et soci\u00e9tal du traitement en cours de d\u00e9veloppement, probl\u00e8mes rencontr\u00e9s lors du d\u00e9veloppement des proc\u00e9d\u00e9s de fabrication et lacunes en termes d\u2019expertise. Le programme s\u2019inscrit dans la logique de\u0026nbsp;\u003Ca href=\u0022https:\/\/www.merckmillipore.com\/DE\/de\/20160513_172534\u0022\u003El\u0027engagement international aux biotechnologies\u003C\/a\u003E\u0026nbsp;de Merck, qui vise \u00e0 faciliter l\u2019acc\u00e8s au march\u00e9 des traitements, en faisant profiter de plusieurs d\u00e9cennies d\u2019expertise en mati\u00e8re de d\u00e9veloppement de proc\u00e9d\u00e9s de fabrication, de produits, et de services \u00e0 la production, quelle qu\u2019en soit l\u2019\u00e9chelle.\u003Ca\u003E\u003C\/a\u003E\u003C\/p\u003E\n\u003Cp\u003EMerck a lanc\u00e9 en 2014 ce programme de soutien aux biotech, qui alterne tous les six mois entre l\u2019Europe, les \u00c9tats-Unis et la Chine. \u00c0 ce jour, la soci\u00e9t\u00e9 a d\u00e9cern\u00e9 pr\u00e8s d\u20191 million d\u2019euros de produits et de services Merck \u00e0 17 soci\u00e9t\u00e9s de biotechnologie dans ces r\u00e9gions. Parmi les anciens laur\u00e9ats europ\u00e9ens on compte les soci\u00e9t\u00e9s\u0026nbsp;\u003Ca href=\u0022https:\/\/www.genequine.com\/en\/\u0022\u003EGeneQuine Biotherapeutics\u003C\/a\u003E\u0026nbsp;(Allemagne),\u0026nbsp;\u003Ca href=\u0022http:\/\/www.reneuron.com\/\u0022\u003EReNeuron\u003C\/a\u003E(Royaume-Uni) ainsi que Magnus Life Science et\u0026nbsp;\u003Ca href=\u0022http:\/\/tiltbio.com\/\u0022\u003ETILT Biotherapeutics\u0026nbsp;\u003C\/a\u003E(Finlande).\u003C\/p\u003E\n\u003Cp\u003EOutre son programme Advance Biotech Grant, Merck a r\u00e9cemment nomm\u00e9 Kytopen laur\u00e9at du programme\u0026nbsp;\u00ab\u0026nbsp;Biotech Start-up\u0026nbsp;\u00bb aux Etats-Unis. Cette soci\u00e9t\u00e9 bas\u00e9e dans le Massachusetts a remport\u00e9 une place \u00e0 LabCentral, le tout premier espace de laboratoire partag\u00e9, o\u00f9 elle poursuit le d\u00e9veloppement de sa technologie exclusive Flowfect\u2122 destin\u00e9e \u00e0 l\u2019administration non virale de mol\u00e9cules dans des cellules immunitaires \u00e0 transfection difficile. La plateforme d\u2019ing\u00e9nierie cellulaire automatis\u00e9e de Kytopen permet d\u2019effectuer de nouvelles d\u00e9couvertes en biologie qui d\u00e9bouchent sur des th\u00e9rapies cellulaires et g\u00e9niques efficaces \u00e0 moindre co\u00fbt.\u003C\/p\u003E\n\u003Cp\u003EVotre contact Presse pour plus d\u0027information\u0026nbsp;Marianne Michel\u003C\/p\u003E\n\u003Cp\u003E\u003Ca href=\u0022https:\/\/www.merckgroup.com\/fr-fr\/news\/traitement-cancer-genoscience-pharma-gliocure-recompenses.html#\u0022\u003EEmail\u003C\/a\u003E\u003C\/p\u003E\n\n\n \u003C\/div\u003E\n \u003Cdiv class=\u0022py-4\u0022\u003E\n \u003Cbutton data-hide-default-content=\u0022false\u0022\n data-label-more=\u0022Voir plus\u0022\n data-label-less=\u0022Voir moins\u0022\n aria-expanded=\u0022false\u0022\n type=\u0022button\u0022\n class=\u0022toggle link\u0022\u003E\n Voir plus\n \u003C\/button\u003E\n \u003C\/div\u003E\n\u003C\/article\u003E\n\u003Carticle class=\u0022carousel-item container-show-more-lines w-full px-4 md:px-8\u0022 role=\u0022group\u0022\u003E\n \u003Cheader class=\u0022space-y-4\u0022\u003E\n \u003Cdiv class=\u0022flex items-center\u0022\u003E\n \u003Cdiv class=\u0022flex-shrink-0 h-10 w-10 max-w-full\u0022\u003E\n \u003Cdiv class=\u0022profile profile--44593 profile--type--profile profile--is-default profile--view-mode--picture clearfix\u0022\u003E\n \n \u003Cimg loading=\u0022lazy\u0022 src=\u0022https:\/\/dr84voq2lwxr8.cloudfront.net\/s3fs-public\/styles\/social_medium\/public\/legacy\/485\/ace651d4-photo-reseaux-sociaux_0.jpg?VersionId=VjaAqehDeVD8Sa2OVWWkbYQGqlLeLcms\u0026amp;itok=oILBrWuF\u0022 width=\u002244\u0022 height=\u002244\u0022 alt=\u0022Profile photo\u0022 class=\u0022image-style-social-medium\u0022 \/\u003E\n\n\n\n\n\u003C\/div\u003E\n\n \u003C\/div\u003E\n \u003Cdiv class=\u0022ml-4 flex-1\u0022\u003E\n \u003Cdiv class=\u0022text-sm\u0022\u003E\n \u003Ca href=\u0022\/fr\/profile\/44593\u0022 class=\u0022font-bold link\u0022\u003ELouis-Marie Bachelot\u003C\/a\u003E\n \u003Cspan\u003E(CEO,\u003C\/span\u003E\n \u003Ca href=\u0022\/fr\/societe\/gliocure\u0022 class=\u0022font-medium link\u0022\u003E\n GlioCure\n \u003C\/a\u003E)\n \u003C\/div\u003E\n \u003Cp class=\u0022text-sm\u0022\u003E\n Publi\u00e9 il y a 6 ans \n \u003C\/p\u003E\n \u003C\/div\u003E\n \u003C\/div\u003E\n\n \u003Ch3 class=\u0022rich-text article\u0022\u003E\n \u003Ca href=\u0022\/fr\/node\/2764\u0022 data-post-title=\u0022Challenges Les 100 meilleures start-up 2018\u0022 data-post-orga-uuid=4d5abf7d-bdd7-493f-bb1b-dcbbdbb1209a\u003E\n \n\u003Cspan\u003EChallenges Les 100 meilleures start-up 2018\u003C\/span\u003E\n\n \u003C\/a\u003E\n \u003C\/h3\u003E\n \u003C\/header\u003E\n \u003Cdiv class=\u0022rich-text content\u0022\u003E\n \u003Cp\u003E\u200bGlioCure\u0026nbsp;au palmar\u00e8s 2018 des magazines Challenges et Sciences \u0026amp; Avenir\u0026nbsp;\u0022Les 100 meilleures start-up\u0022 dans la cat\u00e9gorie sant\u00e9.\u003C\/p\u003E\n\n\n \u003C\/div\u003E\n \u003Cdiv class=\u0022py-4\u0022\u003E\n \u003Cbutton data-hide-default-content=\u0022false\u0022\n data-label-more=\u0022Voir plus\u0022\n data-label-less=\u0022Voir moins\u0022\n aria-expanded=\u0022false\u0022\n type=\u0022button\u0022\n class=\u0022toggle link\u0022\u003E\n Voir plus\n \u003C\/button\u003E\n \u003C\/div\u003E\n\u003C\/article\u003E\n\u003Carticle class=\u0022carousel-item container-show-more-lines w-full px-4 md:px-8\u0022 role=\u0022group\u0022\u003E\n \u003Cheader class=\u0022space-y-4\u0022\u003E\n \u003Cdiv class=\u0022flex items-center\u0022\u003E\n \u003Cdiv class=\u0022flex-shrink-0 h-10 w-10 max-w-full\u0022\u003E\n \u003Cdiv class=\u0022profile profile--44593 profile--type--profile profile--is-default profile--view-mode--picture clearfix\u0022\u003E\n \n \u003Cimg loading=\u0022lazy\u0022 src=\u0022https:\/\/dr84voq2lwxr8.cloudfront.net\/s3fs-public\/styles\/social_medium\/public\/legacy\/485\/ace651d4-photo-reseaux-sociaux_0.jpg?VersionId=VjaAqehDeVD8Sa2OVWWkbYQGqlLeLcms\u0026amp;itok=oILBrWuF\u0022 width=\u002244\u0022 height=\u002244\u0022 alt=\u0022Profile photo\u0022 class=\u0022image-style-social-medium\u0022 \/\u003E\n\n\n\n\n\u003C\/div\u003E\n\n \u003C\/div\u003E\n \u003Cdiv class=\u0022ml-4 flex-1\u0022\u003E\n \u003Cdiv class=\u0022text-sm\u0022\u003E\n \u003Ca href=\u0022\/fr\/profile\/44593\u0022 class=\u0022font-bold link\u0022\u003ELouis-Marie Bachelot\u003C\/a\u003E\n \u003Cspan\u003E(CEO,\u003C\/span\u003E\n \u003Ca href=\u0022\/fr\/societe\/gliocure\u0022 class=\u0022font-medium link\u0022\u003E\n GlioCure\n \u003C\/a\u003E)\n \u003C\/div\u003E\n \u003Cp class=\u0022text-sm\u0022\u003E\n Publi\u00e9 il y a 7 ans \n \u003C\/p\u003E\n \u003C\/div\u003E\n \u003C\/div\u003E\n\n \u003Ch3 class=\u0022rich-text article\u0022\u003E\n \u003Ca href=\u0022\/fr\/node\/2201\u0022 data-post-title=\u0022GlioCure \u00e0 nouveau \u00e0 l\u0026#039;honneur sur BiotechFinances pour le sp\u00e9cial MATWIN\u0022 data-post-orga-uuid=4d5abf7d-bdd7-493f-bb1b-dcbbdbb1209a\u003E\n \n\u003Cspan\u003EGlioCure \u00e0 nouveau \u00e0 l\u0026#039;honneur sur BiotechFinances pour le sp\u00e9cial MATWIN\u003C\/span\u003E\n\n \u003C\/a\u003E\n \u003C\/h3\u003E\n \u003C\/header\u003E\n \u003Cdiv class=\u0022rich-text content\u0022\u003E\n \u003Cp\u003E\u003Ca href=\u0022https:\/\/www.facebook.com\/MATWIN-782815185101260\/\u0022\u003EMATWIN\u003C\/a\u003E\u0026nbsp;a \u00e9t\u00e9 un tremplin pour l\u0027\u00e9mergence de notre anti-mitotique contre le\u0026nbsp;\u003Ca href=\u0022https:\/\/www.facebook.com\/hashtag\/glioblastome?source=feed_text\u0026amp;story_id=289533761480287\u0022\u003E#glioblastome\u003C\/a\u003E\u0026nbsp;issu de l\u0027\u003Ca href=\u0022https:\/\/www.facebook.com\/univangers\/\u0022\u003EUniversit\u00e9 d\u0027Angers\u003C\/a\u003E\u0026nbsp;et de\u0026nbsp;\u003Ca href=\u0022https:\/\/www.facebook.com\/McGillUniversity\/\u0022\u003EMcGill University\u003C\/a\u003E\u003Cbr\u003E\u003Cbr\u003E\nPour nous aider \u00e0 continuer son d\u00e9veloppement apportez-nous votre soutien sur\u0026nbsp;\u003Ca href=\u0022https:\/\/www.facebook.com\/wiseed\/\u0022\u003EWiSEED\u003C\/a\u003E\u003Cbr\u003E\u003Cbr\u003E\n\u0026nbsp;\u003C\/p\u003E\n\n\n \u003C\/div\u003E\n \u003Cdiv class=\u0022py-4\u0022\u003E\n \u003Cbutton data-hide-default-content=\u0022false\u0022\n data-label-more=\u0022Voir plus\u0022\n data-label-less=\u0022Voir moins\u0022\n aria-expanded=\u0022false\u0022\n type=\u0022button\u0022\n class=\u0022toggle link\u0022\u003E\n Voir plus\n \u003C\/button\u003E\n \u003C\/div\u003E\n\u003C\/article\u003E\n\n \u003C\/div\u003E\n \u003C\/div\u003E\n\u003C\/div\u003E\n\u003C\/div\u003E\n\n \n\n\u003Cdiv class=\u0022card px-4 py-5 md:p-8\u0022\u003E\n \u003Cdiv class=\u0022flex justify-between mb-4 relative\u0022\u003E\n \u003Ch2 class=\u0022h4 mb-2 md:mb-4\u0022\u003E\n R\u00e9seau (2)\n \u003C\/h2\u003E\n \u003Cdiv\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022js-tabs\u0022\u003E\n \u003Cdiv class=\u0022flex flex-nowrap items-start overflow-x-auto mb-4 space-x-2\u0022 role=\u0022tablist\u0022\u003E\n \n\n\n\n \n \u003Cbutton class=\u0022button-outlined \u0022\n role=tab\n aria-selected=\u0022false\u0022\n id=tab-1\n \n \u003E\n \n\u003Csvg viewBox=\u00220 0 24 24\u0022\n class=\u0022w-6 h-6 \u0022\n role=\u0022img\u0022\n aria-label=\u0022Soci\u00e9t\u00e9s (0)\u0022\n focusable=\u0022false\u0022\u003E\n \u003Cuse xlink:href=\u0022#symbol-eqt_society\u0022\u003E\u003C\/use\u003E\n\u003C\/svg\u003E\n \u003Cspan class=\u0022pointer-events-none\u0022\u003ESoci\u00e9t\u00e9s (0)\u003C\/span\u003E\n \u003C\/button\u003E\n\n \n\n\n\n \n \u003Cbutton class=\u0022button-outlined \u0022\n role=tab\n aria-selected=\u0022false\u0022\n id=tab-2\n \n \u003E\n \n\u003Csvg viewBox=\u00220 0 24 24\u0022\n class=\u0022w-6 h-6 \u0022\n role=\u0022img\u0022\n aria-label=\u0022Investisseurs (0)\u0022\n focusable=\u0022false\u0022\u003E\n \u003Cuse xlink:href=\u0022#symbol-eqt_investor\u0022\u003E\u003C\/use\u003E\n\u003C\/svg\u003E\n \u003Cspan class=\u0022pointer-events-none\u0022\u003EInvestisseurs (0)\u003C\/span\u003E\n \u003C\/button\u003E\n\n \n\n\n\n \n \u003Cbutton class=\u0022button-outlined \u0022\n role=tab\n aria-selected=\u0022false\u0022\n id=tab-3\n \n \u003E\n \n\u003Csvg viewBox=\u00220 0 24 24\u0022\n class=\u0022w-6 h-6 \u0022\n role=\u0022img\u0022\n aria-label=\u0022Structures d\u0027accompagnement (2)\u0022\n focusable=\u0022false\u0022\u003E\n \u003Cuse xlink:href=\u0022#symbol-eqt_support_structure\u0022\u003E\u003C\/use\u003E\n\u003C\/svg\u003E\n \u003Cspan class=\u0022pointer-events-none\u0022\u003EStructures d\u0027accompagnement (2)\u003C\/span\u003E\n \u003C\/button\u003E\n\n \n\n\n\n \n \u003Cbutton class=\u0022button-outlined \u0022\n role=tab\n aria-selected=\u0022false\u0022\n id=tab-4\n \n \u003E\n \n\u003Csvg viewBox=\u00220 0 24 24\u0022\n class=\u0022w-6 h-6 \u0022\n role=\u0022img\u0022\n aria-label=\u0022Acheteurs (0)\u0022\n focusable=\u0022false\u0022\u003E\n \u003Cuse xlink:href=\u0022#symbol-eqt_buyer\u0022\u003E\u003C\/use\u003E\n\u003C\/svg\u003E\n \u003Cspan class=\u0022pointer-events-none\u0022\u003EAcheteurs (0)\u003C\/span\u003E\n \u003C\/button\u003E\n\n \u003C\/div\u003E\n \u003Cdiv class=\u0022flex flex-nowrap overflow-x-auto md:overflow-x md:grid md:flex-wrap px-4 py-5\u0022\u003E\n \u003Cdiv class=\u0022space-x-4 flex md:grid md:grid-cols-3 gap-4\u0022\n id=\u0022panel-1\u0022\n role=\u0022tabpanel\u0022\n tabindex=\u00220\u0022\n aria-labelledby=\u0022tab-1\u0022\u003E\n \n \u003C\/div\u003E\n \u003Cdiv class=\u0022space-x-4 flex md:grid md:grid-cols-3 gap-4\u0022\n id=\u0022panel-2\u0022\n role=\u0022tabpanel\u0022\n tabindex=\u00220\u0022\n aria-labelledby=\u0022tab-2\u0022\n hidden\u003E\n \n \u003C\/div\u003E\n \u003Cdiv class=\u0022space-x-4 flex md:grid md:grid-cols-3 gap-4\u0022\n id=\u0022panel-3\u0022\n role=\u0022tabpanel\u0022\n tabindex=\u00220\u0022\n aria-labelledby=\u0022tab-3\u0022\n hidden\u003E\n \n\u003Cdiv class=\u0022card rounded-md w-64 md:w-full h-50 mb-4 relative hover:bg-brand-light\u0022\u003E\n \u003Ca class=\u0022w-full\u0022 href=\u0022\/fr\/structure-accompagnement\/institut-carnot-curie-cancer\u0022 title=\u0022Institut Carnot Curie Cancer\u0022\u003E\n \u003Cdiv class=\u0022relative mb-4 md:mb-8 -mt-2\u0022\u003E\n \u003Cfigure role=\u0022presentation\u0022 class=\u0022banner w-full h-20 md:h-30\u0022\u003E\n \u003Cpicture\u003E\n \u003Csource media=\u0022(min-width: 1024px)\u0022 srcset=\u0022\/themes\/custom\/bpi_theme_euroquity\/assets\/images\/fallback\/banner-eqt_support_structure-desktop.png\u0022 \/\u003E\n \u003Csource media=\u0022(max-width: 1023px)\u0022 srcset=\u0022\/themes\/custom\/bpi_theme_euroquity\/assets\/images\/fallback\/banner-eqt_support_structure-desktop.png\u0022 \/\u003E\n \u003Csource media=\u0022(max-width: 767px)\u0022 srcset=\u0022\/themes\/custom\/bpi_theme_euroquity\/assets\/images\/fallback\/banner-eqt_support_structure-mobile.png\u0022 \/\u003E\n \u003Cimg srcset=\u0022\/themes\/custom\/bpi_theme_euroquity\/assets\/images\/fallback\/banner-eqt_support_structure-mobile.png\u0022 loading=\u0022lazy\u0022 alt=\u0022Banner image\u0022 \/\u003E\n \u003C\/picture\u003E\n \u003C\/figure\u003E\n \u003Cdiv class=\u0022container relative\u0022\u003E\n \u003Cdiv class=\u0022pt-12\u0022\u003E\n \u003Cdiv class=\u0022h-20 w-20 md:h-28 md:w-28 absolute top-0 -mt-12 md:-mt-16 page-heading-avatar\u0022\u003E\n \n\n\u003Cdiv class=\u0022aspect-w-1 aspect-h-1\u0022\u003E\n \u003Cimg class=\u0022avatar-squared \u0022\n src=\u0022https:\/\/dr84voq2lwxr8.cloudfront.net\/s3fs-public\/legacy\/460\/aa096c92-carnot_1105_curie-cancer_0.jpg?VersionId=n_DEHMXpwsoPki0xZmYnIAs227oV4_Tt\u0022\n loading=\u0022lazy\u0022\n alt=\u0022Institut Carnot Curie Cancer-logo\u0022 \/\u003E\n\u003C\/div\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022m-4\u0022\u003E\n \u003Cdiv class=\u0022space-y-2 overflow-hidden\u0022\u003E\n \u003Cdiv class=\u0022space-y-0.5\u0022\u003E\n \u003Cdiv class=\u0022flex items-center\u0022\u003E\n \u003Cp class=\u0022h4 flex-1 text-base font-bold text-content-dark truncate\u0022\u003E\n Institut Carnot Curie Cancer\n \u003C\/p\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022flex text-sm\u0022\u003E\n \u003Cp class=\u0022flex ml-3\u0022\u003E\n \u003Cspan class=\u0022block mr-1\u0022\u003E\n \n\u003Csvg viewBox=\u00220 0 24 24\u0022\n class=\u0022w-5 h-5 \u0022\n role=\u0022img\u0022\n aria-label=\u0022Institut Carnot Curie Cancer\u0022\n focusable=\u0022false\u0022\u003E\n \u003Cuse xlink:href=\u0022#symbol-users\u0022\u003E\u003C\/use\u003E\n\u003C\/svg\u003E\n \u003C\/span\u003E\n 1\n \u003C\/p\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022text-sm\u0022\u003E\n R\u00e9seaux d\u0026#039;accompagnement | \n \u003Cdiv class=\u0022py-4\u0022\u003E\n \u003Cdiv class=\u0022rich-text flex gap-1 items-center\u0022\u003E\n France\n \u003Cspan class=\u0022fi fi-fr h-3 leading-3\u0022\u003E\u003C\/span\u003E\n \u003C\/div\u003E\n \u003C\/div\u003E\n\n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022mt-6 mb-8 flex flex-col justify-center\u0022\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/div\u003E\n\u003C\/div\u003E\n \u003C\/a\u003E\n\u003C\/div\u003E\n \n\u003Cdiv class=\u0022card rounded-md w-64 md:w-full h-50 mb-4 relative hover:bg-brand-light\u0022\u003E\n \u003Ca class=\u0022w-full\u0022 href=\u0022\/fr\/structure-accompagnement\/ouest-valorisation\u0022 title=\u0022Ouest Valorisation\u0022\u003E\n \u003Cdiv class=\u0022relative mb-4 md:mb-8 -mt-2\u0022\u003E\n \u003Cfigure role=\u0022presentation\u0022 class=\u0022banner w-full h-20 md:h-30\u0022\u003E\n \u003Cpicture\u003E\n \u003Csource media=\u0022(min-width: 1024px)\u0022 srcset=\u0022\/themes\/custom\/bpi_theme_euroquity\/assets\/images\/fallback\/banner-eqt_support_structure-desktop.png\u0022 \/\u003E\n \u003Csource media=\u0022(max-width: 1023px)\u0022 srcset=\u0022\/themes\/custom\/bpi_theme_euroquity\/assets\/images\/fallback\/banner-eqt_support_structure-desktop.png\u0022 \/\u003E\n \u003Csource media=\u0022(max-width: 767px)\u0022 srcset=\u0022\/themes\/custom\/bpi_theme_euroquity\/assets\/images\/fallback\/banner-eqt_support_structure-mobile.png\u0022 \/\u003E\n \u003Cimg srcset=\u0022\/themes\/custom\/bpi_theme_euroquity\/assets\/images\/fallback\/banner-eqt_support_structure-mobile.png\u0022 loading=\u0022lazy\u0022 alt=\u0022Banner image\u0022 \/\u003E\n \u003C\/picture\u003E\n \u003C\/figure\u003E\n \u003Cdiv class=\u0022container relative\u0022\u003E\n \u003Cdiv class=\u0022pt-12\u0022\u003E\n \u003Cdiv class=\u0022h-20 w-20 md:h-28 md:w-28 absolute top-0 -mt-12 md:-mt-16 page-heading-avatar\u0022\u003E\n \n\n\u003Cdiv class=\u0022aspect-w-1 aspect-h-1\u0022\u003E\n \u003Cimg class=\u0022avatar-squared \u0022\n src=\u0022\/themes\/custom\/bpi_theme_euroquity\/assets\/images\/fallback\/avatar-eqt_organization.png\u0022\n loading=\u0022lazy\u0022\n alt=\u0022Ouest Valorisation-logo\u0022 \/\u003E\n\u003C\/div\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022m-4\u0022\u003E\n \u003Cdiv class=\u0022space-y-2 overflow-hidden\u0022\u003E\n \u003Cdiv class=\u0022space-y-0.5\u0022\u003E\n \u003Cdiv class=\u0022flex items-center\u0022\u003E\n \u003Cp class=\u0022h4 flex-1 text-base font-bold text-content-dark truncate\u0022\u003E\n Ouest Valorisation\n \u003C\/p\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022flex text-sm\u0022\u003E\n \u003Cp class=\u0022flex ml-3\u0022\u003E\n \u003Cspan class=\u0022block mr-1\u0022\u003E\n \n\u003Csvg viewBox=\u00220 0 24 24\u0022\n class=\u0022w-5 h-5 \u0022\n role=\u0022img\u0022\n aria-label=\u0022Ouest Valorisation\u0022\n focusable=\u0022false\u0022\u003E\n \u003Cuse xlink:href=\u0022#symbol-users\u0022\u003E\u003C\/use\u003E\n\u003C\/svg\u003E\n \u003C\/span\u003E\n 2\n \u003C\/p\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022text-sm\u0022\u003E\n Acc\u00e9l\u00e9rateur | \n \u003Cdiv class=\u0022py-4\u0022\u003E\n \u003Cdiv class=\u0022rich-text flex gap-1 items-center\u0022\u003E\n France\n \u003Cspan class=\u0022fi fi-fr h-3 leading-3\u0022\u003E\u003C\/span\u003E\n \u003C\/div\u003E\n \u003C\/div\u003E\n\n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022mt-6 mb-8 flex flex-col justify-center\u0022\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/div\u003E\n\u003C\/div\u003E\n \u003C\/a\u003E\n\u003C\/div\u003E\n\n \u003C\/div\u003E\n \u003Cdiv class=\u0022space-x-4 flex md:grid md:grid-cols-3 gap-4\u0022\n id=\u0022panel-4\u0022\n role=\u0022tabpanel\u0022\n tabindex=\u00220\u0022\n aria-labelledby=\u0022tab-4\u0022\n hidden\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/div\u003E\n\n\n \u003C\/div\u003E\n\n \u003Caside class=\u0022order-first md:order-none md:col-span-4 h-fit space-y-6 min-w-0\u0022\u003E\n \u003Cdiv class=\u0022card relative px-4 md:px-8 mb-4 md:mb-0 py-2.5 md:py-6 js-accordion-mobile-only\u0022\u003E\n \u003Cdiv class=\u0022hidden absolute md:flex gap-x-2 right-0 -top-1 mr-4\u0022\u003E\n \n\n\u003Cdiv class=\u0022relative z-0 p-0 w-14 flex justify-between leading-4 font-bpi font-bold flex-col\ttext-white\u0022\u003E\n \u003Cdiv class=\u0022absolute\u0022\u003E\n \u003Csvg width=\u002258\u0022 height=\u002278\u0022 viewBox=\u00220 0 58 78\u0022 fill=\u0022none\u0022 xmlns=\u0022http:\/\/www.w3.org\/2000\/svg\u0022\u003E\n \u003Cg filter=\u0022url(#filter0_d_909_46606)\u0022\u003E\n \u003Cpath d=\u0022M8 66V4H50V66L30 57.5L8 66Z\u0022 fill=\u0022currentColor\u0022 \/\u003E\n \u003C\/g\u003E\n \u003Cdefs\u003E\n \u003Cfilter id=\u0022filter0_d_909_46606\u0022\n x=\u00220\u0022\n y=\u00220\u0022\n width=\u002258\u0022\n height=\u002278\u0022\n filterUnits=\u0022userSpaceOnUse\u0022\n color-interpolation-filters=\u0022sRGB\u0022\u003E\n \u003CfeFlood flood-opacity=\u00220\u0022 result=\u0022BackgroundImageFix\u0022 \/\u003E\n \u003CfeColorMatrix in=\u0022SourceAlpha\u0022\n type=\u0022matrix\u0022\n values=\u00220 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 127 0\u0022\n result=\u0022hardAlpha\u0022 \/\u003E\n \u003CfeOffset dy=\u00224\u0022 \/\u003E\n \u003CfeGaussianBlur stdDeviation=\u00224\u0022 \/\u003E\n \u003CfeColorMatrix type=\u0022matrix\u0022\n values=\u00220 0 0 0 0 0 0 0 0 0.113725 0 0 0 0 0.290196 0 0 0 0.1 0\u0022 \/\u003E\n \u003CfeBlend mode=\u0022normal\u0022 in2=\u0022BackgroundImageFix\u0022 result=\u0022effect1_dropShadow_909_46606\u0022 \/\u003E\n \u003CfeBlend mode=\u0022normal\u0022\n in=\u0022SourceGraphic\u0022\n in2=\u0022effect1_dropShadow_909_46606\u0022\n result=\u0022shape\u0022 \/\u003E\n \u003C\/filter\u003E\n \u003C\/defs\u003E\n \u003C\/svg\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022mt-2 z-0 flex justify-center \u0022\u003E\n \n\u003Csvg viewBox=\u00220 0 24 24\u0022\n class=\u0022w-6 h-6 \u0022\n role=\u0022img\u0022\n aria-label=\u0022Group EQ Score\u0022\n focusable=\u0022false\u0022\u003E\n \u003Cuse xlink:href=\u0022#symbol-eq_score\u0022\u003E\u003C\/use\u003E\n\u003C\/svg\u003E\n \u003C\/div\u003E\n \u003Cp class=\u0022mb-7 z-0 flex justify-center text-xl leading-none text-content\u0022\u003E\n 97\n \u003C\/p\u003E\n \u003Cdiv class=\u0022gap-6 lg:block md:col-span-12\u0022\u003E\u003C\/div\u003E\n\u003C\/div\u003E\n \n\n\u003Cdiv class=\u0022relative z-0 p-0 w-14 flex justify-between leading-4 font-bpi font-bold flex-col\ttext-purple\u0022\u003E\n \u003Cdiv class=\u0022absolute\u0022\u003E\n \u003Csvg width=\u002258\u0022 height=\u002278\u0022 viewBox=\u00220 0 58 78\u0022 fill=\u0022none\u0022 xmlns=\u0022http:\/\/www.w3.org\/2000\/svg\u0022\u003E\n \u003Cg filter=\u0022url(#filter0_d_909_46606)\u0022\u003E\n \u003Cpath d=\u0022M8 66V4H50V66L30 57.5L8 66Z\u0022 fill=\u0022currentColor\u0022 \/\u003E\n \u003C\/g\u003E\n \u003Cdefs\u003E\n \u003Cfilter id=\u0022filter0_d_909_46606\u0022\n x=\u00220\u0022\n y=\u00220\u0022\n width=\u002258\u0022\n height=\u002278\u0022\n filterUnits=\u0022userSpaceOnUse\u0022\n color-interpolation-filters=\u0022sRGB\u0022\u003E\n \u003CfeFlood flood-opacity=\u00220\u0022 result=\u0022BackgroundImageFix\u0022 \/\u003E\n \u003CfeColorMatrix in=\u0022SourceAlpha\u0022\n type=\u0022matrix\u0022\n values=\u00220 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 127 0\u0022\n result=\u0022hardAlpha\u0022 \/\u003E\n \u003CfeOffset dy=\u00224\u0022 \/\u003E\n \u003CfeGaussianBlur stdDeviation=\u00224\u0022 \/\u003E\n \u003CfeColorMatrix type=\u0022matrix\u0022\n values=\u00220 0 0 0 0 0 0 0 0 0.113725 0 0 0 0 0.290196 0 0 0 0.1 0\u0022 \/\u003E\n \u003CfeBlend mode=\u0022normal\u0022 in2=\u0022BackgroundImageFix\u0022 result=\u0022effect1_dropShadow_909_46606\u0022 \/\u003E\n \u003CfeBlend mode=\u0022normal\u0022\n in=\u0022SourceGraphic\u0022\n in2=\u0022effect1_dropShadow_909_46606\u0022\n result=\u0022shape\u0022 \/\u003E\n \u003C\/filter\u003E\n \u003C\/defs\u003E\n \u003C\/svg\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022mt-2 z-0 flex justify-center text-brand\u0022\u003E\n \n\u003Csvg viewBox=\u00220 0 24 24\u0022\n class=\u0022w-5 h-5 \u0022\n role=\u0022img\u0022\n aria-label=\u0022Group flag count certifications linked\u0022\n focusable=\u0022false\u0022\u003E\n \u003Cuse xlink:href=\u0022#symbol-medal\u0022\u003E\u003C\/use\u003E\n\u003C\/svg\u003E\n \u003C\/div\u003E\n \u003Cp class=\u0022mb-7 z-0 flex justify-center text-xl leading-none text-white\u0022\u003E\n 6\n \u003C\/p\u003E\n \u003Cdiv class=\u0022gap-6 lg:block md:col-span-12\u0022\u003E\u003C\/div\u003E\n\u003C\/div\u003E\n\n \u003C\/div\u003E\n \u003Cdiv class=\u0022flex justify-between mb-3\u0022\u003E\n \u003Cheader class=\u0022flex flex-row items-center mt-3 w-full\u0022\u003E\n \u003Ch2 class=\u0022h5 flex-1 text-content-light\u0022\u003E\n \u003Cbutton aria-expanded=\u0022false\u0022\n aria-controls=\u0022\u0022\n class=\u0022w-full text-left flex items-center\u0022\u003E\n \u003Cspan class=\u0022flex-1\u0022\u003EInformations cl\u00e9s\u003C\/span\u003E\n \u003Cspan class=\u0022transform rotate-90 md:hidden\u0022\u003E\n \n\u003Csvg viewBox=\u00220 0 24 24\u0022\n class=\u0022w-5 h-5 \u0022\n role=\u0022img\u0022\n aria-label=\u0022arrow_forward\u0022\n focusable=\u0022false\u0022\u003E\n \u003Cuse xlink:href=\u0022#symbol-arrow_forward\u0022\u003E\u003C\/use\u003E\n\u003C\/svg\u003E\n \u003C\/span\u003E\n \u003C\/button\u003E\n \u003C\/h2\u003E\n \u003C\/header\u003E\n \u003C\/div\u003E\n \n \u003Cdiv class=\u0022divide-y\u0022 aria-hidden=\u0022false\u0022\u003E\n \n \u003Cdiv class=\u0022py-4\u0022\u003E\n \u003Cheader class=\u0022flex flex-row items-center mb-3\u0022\u003E\n \u003Ch3 class=\u0022h6 flex-1 text-base text-content\u0022\u003E\n Localisation\n \u003C\/h3\u003E\n \u003C\/header\u003E\n \u003Cdiv class=\u0022rich-text flex gap-1 items-center\u0022\u003E\n France\n \u003Cspan class=\u0022fi fi-fr h-3 leading-3\u0022\u003E\u003C\/span\u003E\n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022py-4\u0022\u003E\n \u003Cheader class=\u0022flex flex-row items-center mb-3\u0022\u003E\n \u003Ch3 class=\u0022h6 flex-1 text-base text-content\u0022\u003E\n Secteur(s) d\u0026#039;activit\u00e9\n \u003C\/h3\u003E\n \u003C\/header\u003E\n \u003Cdiv class=\u0022inline-block mr-1 mb-2\u0022\u003E\n \n\u003Cdiv class=\u0022badge\u0022\u003E\n \u003Cspan\u003EBiotech\u003C\/span\u003E\n\u003C\/div\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022inline-block mr-1 mb-2\u0022\u003E\n \n\u003Cdiv class=\u0022badge\u0022\u003E\n \u003Cspan\u003EDeeptech\u003C\/span\u003E\n\u003C\/div\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022inline-block mr-1 mb-2\u0022\u003E\n \n\u003Cdiv class=\u0022badge\u0022\u003E\n \u003Cspan\u003ESant\u00e9\u003C\/span\u003E\n\u003C\/div\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022inline-block mr-1 mb-2\u0022\u003E\n \n\u003Cdiv class=\u0022badge\u0022\u003E\n \u003Cspan\u003EMedtech\u003C\/span\u003E\n\u003C\/div\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022inline-block mr-1 mb-2\u0022\u003E\n \n\u003Cdiv class=\u0022badge\u0022\u003E\n \u003Cspan\u003ESant\u00e9 num\u00e9rique\u003C\/span\u003E\n\u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/div\u003E\n\u003Cdiv class=\u0022py-4\u0022\u003E\n \u003Cheader class=\u0022flex flex-row items-center mb-3\u0022\u003E\n \u003Ch3 class=\u0022h6 flex-1 text-base text-content\u0022\u003E\n Chiffres cl\u00e9s\n \u003C\/h3\u003E\n \u003C\/header\u003E\n \u003Cdiv class=\u0022space-y-2\u0022\u003E\n \n \u003Cdiv class=\u0022field field--group field--name-field-creation-date field--type-datetime flex items-center py-2\u0022\u003E\n \u003Cdt class=\u0022flex-1 \u0022\u003E\n Date de cr\u00e9ation\n \u003C\/dt\u003E\n \u003Cdd class=\u0022flex-1 text-right font-bold pl-6 break-all\u0022\u003E\u003Ctime datetime=\u00222016-09-07T12:00:00Z\u0022\u003E07\/09\/2016\u003C\/time\u003E\n\u003C\/dd\u003E\n \u003C\/div\u003E\n\n \u003C\/div\u003E\n\u003C\/div\u003E\n\u003Cdiv class=\u0022py-4\u0022\u003E\n \u003Cheader class=\u0022flex flex-row items-center mb-3\u0022\u003E\n \u003Ch3 class=\u0022h6 flex-1 text-base text-content\u0022\u003E\n Nous suivre\n \u003C\/h3\u003E\n \u003C\/header\u003E\n \n\n \u003Ca href=\u0022http:\/\/www.gliocure.com\/\u0022 target=\u0022_blank\u0022 class=\u0022field field--group field--name-field-website field--type-link flex my-4\u0022\u003E\n \n\u003Csvg viewBox=\u00220 0 24 24\u0022\n class=\u0022w-6 h-6 \u0022\n role=\u0022img\u0022\n aria-label=\u0022Site web\u0022\n focusable=\u0022false\u0022\u003E\n \u003Cuse xlink:href=\u0022#symbol-language_24px\u0022\u003E\u003C\/use\u003E\n\u003C\/svg\u003E\n \u003Cp class=\u0022ml-4 underline link\u0022\u003E\n Site web\n \u003C\/p\u003E\n \u003C\/a\u003E\n\n \n \u003Ca href=\u0022https:\/\/twitter.com\/LMB_GlioCure\u0022 target=\u0022_blank\u0022 class=\u0022field field--group field--name-field-twitter field--type-link flex my-4\u0022\u003E\n \n\u003Csvg viewBox=\u00220 0 24 24\u0022\n class=\u0022w-6 h-6 \u0022\n role=\u0022img\u0022\n aria-label=\u0022Compte Twitter de votre organisation\u0022\n focusable=\u0022false\u0022\u003E\n \u003Cuse xlink:href=\u0022#symbol-twitter\u0022\u003E\u003C\/use\u003E\n\u003C\/svg\u003E\n \u003Cp class=\u0022ml-4 underline link\u0022\u003E\n Twitter\n \u003C\/p\u003E\n \u003C\/a\u003E\n\n\n \u003Ca href=\u0022https:\/\/www.linkedin.com\/in\/louis-marie-bachelot-5984ab?trk=hp-identity-name\u0022 target=\u0022_blank\u0022 class=\u0022field field--group field--name-field-linkedin field--type-link flex my-4\u0022\u003E\n \n\u003Csvg viewBox=\u00220 0 24 24\u0022\n class=\u0022w-6 h-6 \u0022\n role=\u0022img\u0022\n aria-label=\u0022Compte Linkedin de votre organisation\u0022\n focusable=\u0022false\u0022\u003E\n \u003Cuse xlink:href=\u0022#symbol-linkedIn\u0022\u003E\u003C\/use\u003E\n\u003C\/svg\u003E\n \u003Cp class=\u0022ml-4 underline link\u0022\u003E\n Linkedin\n \u003C\/p\u003E\n \u003C\/a\u003E\n\n\u003C\/div\u003E\n\n \u003C\/div\u003E\n\u003C\/div\u003E\n \u003C\/aside\u003E\n \n \u003Cdiv class=\u0022md:col-span-4 h-fit space-y-6 min-w-0\u0022\u003E\n \u003Cdiv class=\u0022card px-4 md:px-8 py-5 md:py-6 js-accordion overflow-visible\u0022\u003E\n \u003Cdiv\u003E\n \u003Cheader class=\u0022mb-3\u0022\u003E\n \u003Ch3 class=\u0022h5\u0022\u003E\n \u003Cbutton aria-expanded=\u0022false\u0022\n aria-controls=\u0022\u0022\n class=\u0022w-full text-left flex items-center mb-3 h5\u0022\n \u003E\n \u003Cspan class=\u0022flex-1 text-content-light\u0022\u003E\n Communaut\u00e9s (7) \u003C\/span\u003E\n \u003Cspan class=\u0022transform rotate-90\u0022\u003E\n \n\u003Csvg viewBox=\u00220 0 24 24\u0022\n class=\u0022w-5 h-5 \u0022\n role=\u0022img\u0022\n aria-label=\u0022Group communities linked\u0022\n focusable=\u0022false\u0022\u003E\n \u003Cuse xlink:href=\u0022#symbol-arrow_forward\u0022\u003E\u003C\/use\u003E\n\u003C\/svg\u003E\n \u003C\/span\u003E\n \u003C\/button\u003E\n \u003C\/h3\u003E\n \u003C\/header\u003E\n \u003Cdiv class=\u0022divide-y\u0022\u003E\n \u003Cdiv class=\u0022flex justify-between space-x-4 items-center\u0022\u003E\n \u003Ca href=\u0022\/fr\/communaute\/bpifrance\u0022\n title=\u0022 Bpifrance\n\u0022\n class=\u0022transition-colors bg-white hover:bg-opacity-50 hover:bg-brand-light rounded-md hover:border-solid hover:border-gray-50 -mx-2 w-full min-w-0\u0022\u003E\n \u003Cdiv class=\u0022flex space-x-4 p-2\u0022\u003E\n \u003Cdiv class=\u0022flex-shrink-0 h-10 w-10 max-w-full profile\u0022\u003E\n \u003Cimg loading=\u0022lazy\u0022 src=\u0022https:\/\/dr84voq2lwxr8.cloudfront.net\/s3fs-public\/styles\/social_medium\/public\/legacy\/349\/b2d2410f-b2d2410f-7b29-4453-95e4-5c8b6f529d18_0.png?VersionId=72RvTVbvM6J936sCmKXH0mJgckCC3lCl\u0026amp;itok=PrqmTE00\u0022 width=\u002244\u0022 height=\u002244\u0022 alt=\u0022Logo\u0022 class=\u0022image-style-social-medium\u0022 \/\u003E\n\n\n\n\n \u003C\/div\u003E\n \u003Cdiv class=\u0022flex-1 overflow-hidden\u0022\u003E\n \u003Cdiv class=\u0022text-sm font-bold text-content-dark truncate\u0022\u003E\n Bpifrance\n\n \u003C\/div\u003E\n \u003Cdiv class=\u0022text-sm text-content-dark truncate\u0022\u003E\n \n \u003C\/div\u003E\n \u003Cdiv class=\u0022text-sm text-content-dark truncate\u0022\u003E\n \u003Cp class=\u0022flex items-center space-x-1\u0022\u003E\n \u003Cspan class=\u0022text-content\u0022\u003E\u003Cem class=\u0022placeholder\u0022\u003E2417\u003C\/em\u003E membres\u003C\/span\u003E\n \u003C\/p\u003E\n\n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/a\u003E\n \u003C\/div\u003E\n\n\n \u003Cdiv class=\u0022flex justify-between space-x-4 items-center\u0022\u003E\n \u003Ca href=\u0022\/fr\/communaute\/invest-horizon\u0022\n title=\u0022 InvestHorizon\n\u0022\n class=\u0022transition-colors bg-white hover:bg-opacity-50 hover:bg-brand-light rounded-md hover:border-solid hover:border-gray-50 -mx-2 w-full min-w-0\u0022\u003E\n \u003Cdiv class=\u0022flex space-x-4 p-2\u0022\u003E\n \u003Cdiv class=\u0022flex-shrink-0 h-10 w-10 max-w-full profile\u0022\u003E\n \u003Cimg loading=\u0022lazy\u0022 src=\u0022https:\/\/dr84voq2lwxr8.cloudfront.net\/s3fs-public\/styles\/social_medium\/public\/legacy\/1164\/9141b6a1-logo-orange-notext-2x_0.png?VersionId=MGl14aWBrWu.NCBQsdFKABMDBbMDvB5N\u0026amp;itok=EzAxxDUk\u0022 width=\u002244\u0022 height=\u002244\u0022 alt=\u0022Logo\u0022 class=\u0022image-style-social-medium\u0022 \/\u003E\n\n\n\n\n \u003C\/div\u003E\n \u003Cdiv class=\u0022flex-1 overflow-hidden\u0022\u003E\n \u003Cdiv class=\u0022text-sm font-bold text-content-dark truncate\u0022\u003E\n InvestHorizon\n\n \u003C\/div\u003E\n \u003Cdiv class=\u0022text-sm text-content-dark truncate\u0022\u003E\n \n \u003C\/div\u003E\n \u003Cdiv class=\u0022text-sm text-content-dark truncate\u0022\u003E\n \u003Cp class=\u0022flex items-center space-x-1\u0022\u003E\n \u003Cspan class=\u0022text-content\u0022\u003E\u003Cem class=\u0022placeholder\u0022\u003E2644\u003C\/em\u003E membres\u003C\/span\u003E\n \u003C\/p\u003E\n\n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/a\u003E\n \u003C\/div\u003E\n\n\n \u003Cdiv class=\u0022flex justify-between space-x-4 items-center\u0022\u003E\n \u003Ca href=\u0022\/fr\/communaute\/satt\u0022\n title=\u0022 SATT\n\u0022\n class=\u0022transition-colors bg-white hover:bg-opacity-50 hover:bg-brand-light rounded-md hover:border-solid hover:border-gray-50 -mx-2 w-full min-w-0\u0022\u003E\n \u003Cdiv class=\u0022flex space-x-4 p-2\u0022\u003E\n \u003Cdiv class=\u0022flex-shrink-0 h-10 w-10 max-w-full profile\u0022\u003E\n \u003Cimg loading=\u0022lazy\u0022 src=\u0022https:\/\/dr84voq2lwxr8.cloudfront.net\/s3fs-public\/styles\/social_medium\/public\/legacy\/1933\/84b898f0-image-de-profil_0.png?VersionId=8RMFA7GILzaLslkG5XubQt2lSTxKf2vN\u0026amp;itok=QLSpQxYV\u0022 width=\u002244\u0022 height=\u002244\u0022 alt=\u0022Logo\u0022 class=\u0022image-style-social-medium\u0022 \/\u003E\n\n\n\n\n \u003C\/div\u003E\n \u003Cdiv class=\u0022flex-1 overflow-hidden\u0022\u003E\n \u003Cdiv class=\u0022text-sm font-bold text-content-dark truncate\u0022\u003E\n SATT\n\n \u003C\/div\u003E\n \u003Cdiv class=\u0022text-sm text-content-dark truncate\u0022\u003E\n \n \u003C\/div\u003E\n \u003Cdiv class=\u0022text-sm text-content-dark truncate\u0022\u003E\n \u003Cp class=\u0022flex items-center space-x-1\u0022\u003E\n \u003Cspan class=\u0022text-content\u0022\u003E\u003Cem class=\u0022placeholder\u0022\u003E302\u003C\/em\u003E membres\u003C\/span\u003E\n \u003C\/p\u003E\n\n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/a\u003E\n \u003C\/div\u003E\n\n\n \u003C\/div\u003E\n \u003Cdiv role=\u0022region\u0022 aria-hidden=\u0022true\u0022\u003E\n \u003Cdiv class=\u0022divide-y border-t\u0022\u003E\n \u003Cdiv class=\u0022flex justify-between space-x-4 items-center\u0022\u003E\n \u003Ca href=\u0022\/fr\/communaute\/access2eic\u0022\n title=\u0022 Access2EIC\n\u0022\n class=\u0022transition-colors bg-white hover:bg-opacity-50 hover:bg-brand-light rounded-md hover:border-solid hover:border-gray-50 -mx-2 w-full min-w-0\u0022\u003E\n \u003Cdiv class=\u0022flex space-x-4 p-2\u0022\u003E\n \u003Cdiv class=\u0022flex-shrink-0 h-10 w-10 max-w-full profile\u0022\u003E\n \u003Cimg loading=\u0022lazy\u0022 src=\u0022https:\/\/dr84voq2lwxr8.cloudfront.net\/s3fs-public\/styles\/social_medium\/public\/legacy\/1332\/0c745e11-logo-access2eic_0.png?VersionId=pE3EBY6xwu7V28ujKkP412z._3nYU9bm\u0026amp;itok=Z-BAr35z\u0022 width=\u002244\u0022 height=\u002244\u0022 alt=\u0022Logo\u0022 class=\u0022image-style-social-medium\u0022 \/\u003E\n\n\n\n\n \u003C\/div\u003E\n \u003Cdiv class=\u0022flex-1 overflow-hidden\u0022\u003E\n \u003Cdiv class=\u0022text-sm font-bold text-content-dark truncate\u0022\u003E\n Access2EIC\n\n \u003C\/div\u003E\n \u003Cdiv class=\u0022text-sm text-content-dark truncate\u0022\u003E\n \n \u003C\/div\u003E\n \u003Cdiv class=\u0022text-sm text-content-dark truncate\u0022\u003E\n \u003Cp class=\u0022flex items-center space-x-1\u0022\u003E\n \u003Cspan class=\u0022text-content\u0022\u003E\u003Cem class=\u0022placeholder\u0022\u003E2258\u003C\/em\u003E membres\u003C\/span\u003E\n \u003C\/p\u003E\n\n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/a\u003E\n \u003C\/div\u003E\n\n\n \u003Cdiv class=\u0022flex justify-between space-x-4 items-center\u0022\u003E\n \u003Ca href=\u0022\/fr\/communaute\/deeptech\u0022\n title=\u0022 Les Deeptech\n\u0022\n class=\u0022transition-colors bg-white hover:bg-opacity-50 hover:bg-brand-light rounded-md hover:border-solid hover:border-gray-50 -mx-2 w-full min-w-0\u0022\u003E\n \u003Cdiv class=\u0022flex space-x-4 p-2\u0022\u003E\n \u003Cdiv class=\u0022flex-shrink-0 h-10 w-10 max-w-full profile\u0022\u003E\n \u003Cimg loading=\u0022lazy\u0022 src=\u0022https:\/\/dr84voq2lwxr8.cloudfront.net\/s3fs-public\/styles\/social_medium\/public\/legacy\/1671\/2e78195e-lesdeeptech_circ-blanc_rvb_0.png?VersionId=Sb9zQxVWXxOH0XfSFPJSDVtvPeCpuAQw\u0026amp;itok=plQzQnv4\u0022 width=\u002244\u0022 height=\u002244\u0022 alt=\u0022Logo\u0022 class=\u0022image-style-social-medium\u0022 \/\u003E\n\n\n\n\n \u003C\/div\u003E\n \u003Cdiv class=\u0022flex-1 overflow-hidden\u0022\u003E\n \u003Cdiv class=\u0022text-sm font-bold text-content-dark truncate\u0022\u003E\n Les Deeptech\n\n \u003C\/div\u003E\n \u003Cdiv class=\u0022text-sm text-content-dark truncate\u0022\u003E\n \n \u003C\/div\u003E\n \u003Cdiv class=\u0022text-sm text-content-dark truncate\u0022\u003E\n \u003Cp class=\u0022flex items-center space-x-1\u0022\u003E\n \u003Cspan class=\u0022text-content\u0022\u003E\u003Cem class=\u0022placeholder\u0022\u003E433\u003C\/em\u003E membres\u003C\/span\u003E\n \u003C\/p\u003E\n\n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/a\u003E\n \u003C\/div\u003E\n\n\n \u003Cdiv class=\u0022flex justify-between space-x-4 items-center\u0022\u003E\n \u003Ca href=\u0022\/fr\/communaute\/eic-accelerator-france\u0022\n title=\u0022 EIC Accelerator France\n\u0022\n class=\u0022transition-colors bg-white hover:bg-opacity-50 hover:bg-brand-light rounded-md hover:border-solid hover:border-gray-50 -mx-2 w-full min-w-0\u0022\u003E\n \u003Cdiv class=\u0022flex space-x-4 p-2\u0022\u003E\n \u003Cdiv class=\u0022flex-shrink-0 h-10 w-10 max-w-full profile\u0022\u003E\n \u003Cimg loading=\u0022lazy\u0022 src=\u0022https:\/\/dr84voq2lwxr8.cloudfront.net\/s3fs-public\/styles\/social_medium\/public\/legacy\/2801\/087069c4-microsoftteams-image-6-_0.png?VersionId=YQGpXW6PdnSgZ5SNUh4ItmSK2E4qHoA9\u0026amp;itok=04-tVpVx\u0022 width=\u002244\u0022 height=\u002244\u0022 alt=\u0022Logo\u0022 class=\u0022image-style-social-medium\u0022 \/\u003E\n\n\n\n\n \u003C\/div\u003E\n \u003Cdiv class=\u0022flex-1 overflow-hidden\u0022\u003E\n \u003Cdiv class=\u0022text-sm font-bold text-content-dark truncate\u0022\u003E\n EIC Accelerator France\n\n \u003C\/div\u003E\n \u003Cdiv class=\u0022text-sm text-content-dark truncate\u0022\u003E\n \n \u003C\/div\u003E\n \u003Cdiv class=\u0022text-sm text-content-dark truncate\u0022\u003E\n \u003Cp class=\u0022flex items-center space-x-1\u0022\u003E\n \u003Cspan class=\u0022text-content\u0022\u003E\u003Cem class=\u0022placeholder\u0022\u003E455\u003C\/em\u003E membres\u003C\/span\u003E\n \u003C\/p\u003E\n\n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/a\u003E\n \u003C\/div\u003E\n\n\n \u003Cdiv class=\u0022flex justify-between space-x-4 items-center\u0022\u003E\n \u003Ca href=\u0022\/fr\/communaute\/techglow-eu\u0022\n title=\u0022 TechGlow EU\n\u0022\n class=\u0022transition-colors bg-white hover:bg-opacity-50 hover:bg-brand-light rounded-md hover:border-solid hover:border-gray-50 -mx-2 w-full min-w-0\u0022\u003E\n \u003Cdiv class=\u0022flex space-x-4 p-2\u0022\u003E\n \u003Cdiv class=\u0022flex-shrink-0 h-10 w-10 max-w-full profile\u0022\u003E\n \u003Cimg loading=\u0022lazy\u0022 src=\u0022https:\/\/dr84voq2lwxr8.cloudfront.net\/s3fs-public\/styles\/social_medium\/public\/2024-08\/TechGlow%20EU.png?VersionId=fed1WmpAiIe3RmwxdqMY4xUGBlngxN34\u0026amp;itok=RM_H-JzF\u0022 width=\u002244\u0022 height=\u002244\u0022 alt=\u0022Logo TechGlow EU \u0022 class=\u0022image-style-social-medium\u0022 \/\u003E\n\n\n\n\n \u003C\/div\u003E\n \u003Cdiv class=\u0022flex-1 overflow-hidden\u0022\u003E\n \u003Cdiv class=\u0022text-sm font-bold text-content-dark truncate\u0022\u003E\n TechGlow EU\n\n \u003C\/div\u003E\n \u003Cdiv class=\u0022text-sm text-content-dark truncate\u0022\u003E\n \n \u003C\/div\u003E\n \u003Cdiv class=\u0022text-sm text-content-dark truncate\u0022\u003E\n \u003Cp class=\u0022flex items-center space-x-1\u0022\u003E\n \u003Cspan class=\u0022text-content\u0022\u003E\u003Cem class=\u0022placeholder\u0022\u003E163\u003C\/em\u003E membres\u003C\/span\u003E\n \u003C\/p\u003E\n\n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/a\u003E\n \u003Cdiv class=\u0022flex items-center\u0022\u003E\n \n\u003Cdiv class=\u0022badge\u0022\u003E\n \u003Cspan\u003EAustria\u003C\/span\u003E\n\u003C\/div\u003E\n \u003Cp class=\u0022ml-2 whitespace-nowrap text-sm\u0022\u003E\n + 47\n \u003C\/p\u003E\n \u003C\/div\u003E\n \u003C\/div\u003E\n\n\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n\u003C\/div\u003E\n\u003Cdiv class=\u0022card px-4 md:px-8 py-5 md:py-6 js-accordion overflow-visible\u0022\u003E\n \u003Cdiv\u003E\n \u003Cheader class=\u0022mb-3\u0022\u003E\n \u003Ch3 class=\u0022h5\u0022\u003E\n \u003Cbutton aria-expanded=\u0022false\u0022\n aria-controls=\u0022\u0022\n class=\u0022w-full text-left flex items-center mb-3 h5\u0022\n \u003E\n \u003Cspan class=\u0022flex-1 text-content-light\u0022\u003E\n Labels (6) \u003C\/span\u003E\n \u003Cspan class=\u0022transform rotate-90\u0022\u003E\n \n\u003Csvg viewBox=\u00220 0 24 24\u0022\n class=\u0022w-5 h-5 \u0022\n role=\u0022img\u0022\n aria-label=\u0022Group certifications linked\u0022\n focusable=\u0022false\u0022\u003E\n \u003Cuse xlink:href=\u0022#symbol-arrow_forward\u0022\u003E\u003C\/use\u003E\n\u003C\/svg\u003E\n \u003C\/span\u003E\n \u003C\/button\u003E\n \u003C\/h3\u003E\n \u003C\/header\u003E\n \u003Cdiv class=\u0022divide-y\u0022\u003E\n \u003Cdiv class=\u0022flex justify-between space-x-4 items-center\u0022\u003E\n \u003Ca href=\u0022\/fr\/label\/seal-excellence\u0022\n title=\u0022 Seal of Excellence\n\u0022\n class=\u0022transition-colors bg-white hover:bg-opacity-50 hover:bg-brand-light rounded-md hover:border-solid hover:border-gray-50 -mx-2 w-full min-w-0\u0022\u003E\n \u003Cdiv class=\u0022flex space-x-4 p-2\u0022\u003E\n \u003Cdiv class=\u0022flex-shrink-0 h-10 w-10 max-w-full profile\u0022\u003E\n \u003Cimg loading=\u0022lazy\u0022 src=\u0022https:\/\/dr84voq2lwxr8.cloudfront.net\/s3fs-public\/styles\/social_medium\/public\/legacy\/528\/ac69c57c-soe2_0.png?VersionId=n8Rv97ht10UWN4M0RalVH5MT544U2FLf\u0026amp;itok=cw2Nqw-3\u0022 width=\u002244\u0022 height=\u002244\u0022 alt=\u0022Logo\u0022 class=\u0022image-style-social-medium\u0022 \/\u003E\n\n\n\n\n \u003C\/div\u003E\n \u003Cdiv class=\u0022flex-1 overflow-hidden\u0022\u003E\n \u003Cdiv class=\u0022text-sm font-bold text-content-dark truncate\u0022\u003E\n Seal of Excellence\n\n \u003C\/div\u003E\n \u003Cdiv class=\u0022text-sm text-content-dark truncate\u0022\u003E\n \n \u003C\/div\u003E\n \u003Cdiv class=\u0022text-sm text-content-dark truncate\u0022\u003E\n \u003Cp class=\u0022flex items-center space-x-1\u0022\u003E\n \u003Cspan class=\u0022text-content\u0022\u003E\u003Cem class=\u0022placeholder\u0022\u003E1563\u003C\/em\u003E organisations labellis\u00e9es\u003C\/span\u003E\n \u003C\/p\u003E\n\n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/a\u003E\n \u003C\/div\u003E\n\n\n \u003Cdiv class=\u0022flex justify-between space-x-4 items-center\u0022\u003E\n \u003Ca href=\u0022\/fr\/label\/ap-hp\u0022\n title=\u0022 AP-HP\n\u0022\n class=\u0022transition-colors bg-white hover:bg-opacity-50 hover:bg-brand-light rounded-md hover:border-solid hover:border-gray-50 -mx-2 w-full min-w-0\u0022\u003E\n \u003Cdiv class=\u0022flex space-x-4 p-2\u0022\u003E\n \u003Cdiv class=\u0022flex-shrink-0 h-10 w-10 max-w-full profile\u0022\u003E\n \u003Cimg loading=\u0022lazy\u0022 src=\u0022https:\/\/dr84voq2lwxr8.cloudfront.net\/s3fs-public\/styles\/social_medium\/public\/legacy\/1905\/671d7355-2014-logo-ap-hp-cmjn_0.png?VersionId=mAJQungCR0k3VKm4.E8WT6pWu.PRuj0K\u0026amp;itok=Q0XMjN0E\u0022 width=\u002244\u0022 height=\u002244\u0022 alt=\u0022Logo\u0022 class=\u0022image-style-social-medium\u0022 \/\u003E\n\n\n\n\n \u003C\/div\u003E\n \u003Cdiv class=\u0022flex-1 overflow-hidden\u0022\u003E\n \u003Cdiv class=\u0022text-sm font-bold text-content-dark truncate\u0022\u003E\n AP-HP\n\n \u003C\/div\u003E\n \u003Cdiv class=\u0022text-sm text-content-dark truncate\u0022\u003E\n \n \u003C\/div\u003E\n \u003Cdiv class=\u0022text-sm text-content-dark truncate\u0022\u003E\n \u003Cp class=\u0022flex items-center space-x-1\u0022\u003E\n \u003Cspan class=\u0022text-content\u0022\u003E\u003Cem class=\u0022placeholder\u0022\u003E15\u003C\/em\u003E organisations labellis\u00e9es\u003C\/span\u003E\n \u003C\/p\u003E\n\n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/a\u003E\n \u003C\/div\u003E\n\n\n \u003Cdiv class=\u0022flex justify-between space-x-4 items-center\u0022\u003E\n \u003Ca href=\u0022\/fr\/label\/inserm-transfert\u0022\n title=\u0022 INSERM Transfert\n\u0022\n class=\u0022transition-colors bg-white hover:bg-opacity-50 hover:bg-brand-light rounded-md hover:border-solid hover:border-gray-50 -mx-2 w-full min-w-0\u0022\u003E\n \u003Cdiv class=\u0022flex space-x-4 p-2\u0022\u003E\n \u003Cdiv class=\u0022flex-shrink-0 h-10 w-10 max-w-full profile\u0022\u003E\n \u003Cimg loading=\u0022lazy\u0022 src=\u0022https:\/\/dr84voq2lwxr8.cloudfront.net\/s3fs-public\/styles\/social_medium\/public\/legacy\/1922\/9aea2055-logo-inserm-transfert_0.jpg?VersionId=Sd59yzbm4s.WN1m72s7x5OYIX3lc4iIA\u0026amp;itok=QFyRFu49\u0022 width=\u002244\u0022 height=\u002244\u0022 alt=\u0022Logo\u0022 class=\u0022image-style-social-medium\u0022 \/\u003E\n\n\n\n\n \u003C\/div\u003E\n \u003Cdiv class=\u0022flex-1 overflow-hidden\u0022\u003E\n \u003Cdiv class=\u0022text-sm font-bold text-content-dark truncate\u0022\u003E\n INSERM Transfert\n\n \u003C\/div\u003E\n \u003Cdiv class=\u0022text-sm text-content-dark truncate\u0022\u003E\n \n \u003C\/div\u003E\n \u003Cdiv class=\u0022text-sm text-content-dark truncate\u0022\u003E\n \u003Cp class=\u0022flex items-center space-x-1\u0022\u003E\n \u003Cspan class=\u0022text-content\u0022\u003E\u003Cem class=\u0022placeholder\u0022\u003E6\u003C\/em\u003E organisations labellis\u00e9es\u003C\/span\u003E\n \u003C\/p\u003E\n\n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/a\u003E\n \u003C\/div\u003E\n\n\n \u003C\/div\u003E\n \u003Cdiv role=\u0022region\u0022 aria-hidden=\u0022true\u0022\u003E\n \u003Cdiv class=\u0022divide-y border-t\u0022\u003E\n \u003Cdiv class=\u0022flex justify-between space-x-4 items-center\u0022\u003E\n \u003Ca href=\u0022\/fr\/label\/beneficiaires-french-tech-seed\u0022\n title=\u0022 B\u00e9n\u00e9ficiaires French Tech Seed\n\u0022\n class=\u0022transition-colors bg-white hover:bg-opacity-50 hover:bg-brand-light rounded-md hover:border-solid hover:border-gray-50 -mx-2 w-full min-w-0\u0022\u003E\n \u003Cdiv class=\u0022flex space-x-4 p-2\u0022\u003E\n \u003Cdiv class=\u0022flex-shrink-0 h-10 w-10 max-w-full profile\u0022\u003E\n \u003Cimg loading=\u0022lazy\u0022 src=\u0022https:\/\/dr84voq2lwxr8.cloudfront.net\/s3fs-public\/styles\/social_medium\/public\/legacy\/1322\/2286ea8d-fts-logo_0.jpg?VersionId=VXVcfRkPwepTDQjpBcQWVgoKvpAUEXx9\u0026amp;itok=WFBNRfeh\u0022 width=\u002244\u0022 height=\u002244\u0022 alt=\u0022Logo\u0022 class=\u0022image-style-social-medium\u0022 \/\u003E\n\n\n\n\n \u003C\/div\u003E\n \u003Cdiv class=\u0022flex-1 overflow-hidden\u0022\u003E\n \u003Cdiv class=\u0022text-sm font-bold text-content-dark truncate\u0022\u003E\n B\u00e9n\u00e9ficiaires French Tech Seed\n\n \u003C\/div\u003E\n \u003Cdiv class=\u0022text-sm text-content-dark truncate\u0022\u003E\n \n \u003C\/div\u003E\n \u003Cdiv class=\u0022text-sm text-content-dark truncate\u0022\u003E\n \u003Cp class=\u0022flex items-center space-x-1\u0022\u003E\n \u003Cspan class=\u0022text-content\u0022\u003E\u003Cem class=\u0022placeholder\u0022\u003E60\u003C\/em\u003E organisations labellis\u00e9es\u003C\/span\u003E\n \u003C\/p\u003E\n\n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/a\u003E\n \u003C\/div\u003E\n\n\n \u003Cdiv class=\u0022flex justify-between space-x-4 items-center\u0022\u003E\n \u003Ca href=\u0022\/fr\/label\/satt-ouest-valorisation\u0022\n title=\u0022 SATT Ouest Valorisation\n\u0022\n class=\u0022transition-colors bg-white hover:bg-opacity-50 hover:bg-brand-light rounded-md hover:border-solid hover:border-gray-50 -mx-2 w-full min-w-0\u0022\u003E\n \u003Cdiv class=\u0022flex space-x-4 p-2\u0022\u003E\n \u003Cdiv class=\u0022flex-shrink-0 h-10 w-10 max-w-full profile\u0022\u003E\n \u003Cimg loading=\u0022lazy\u0022 src=\u0022https:\/\/dr84voq2lwxr8.cloudfront.net\/s3fs-public\/styles\/social_medium\/public\/legacy\/1912\/5e5ff061-logo-ouest-valosation-baseline_0.png?VersionId=yY8ItA.4fwCPWZlqx3IJxRs7My4tmi6o\u0026amp;itok=uFBJRX5C\u0022 width=\u002244\u0022 height=\u002244\u0022 alt=\u0022Logo\u0022 class=\u0022image-style-social-medium\u0022 \/\u003E\n\n\n\n\n \u003C\/div\u003E\n \u003Cdiv class=\u0022flex-1 overflow-hidden\u0022\u003E\n \u003Cdiv class=\u0022text-sm font-bold text-content-dark truncate\u0022\u003E\n SATT Ouest Valorisation\n\n \u003C\/div\u003E\n \u003Cdiv class=\u0022text-sm text-content-dark truncate\u0022\u003E\n \n \u003C\/div\u003E\n \u003Cdiv class=\u0022text-sm text-content-dark truncate\u0022\u003E\n \u003Cp class=\u0022flex items-center space-x-1\u0022\u003E\n \u003Cspan class=\u0022text-content\u0022\u003E\u003Cem class=\u0022placeholder\u0022\u003E4\u003C\/em\u003E organisations labellis\u00e9es\u003C\/span\u003E\n \u003C\/p\u003E\n\n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/a\u003E\n \u003C\/div\u003E\n\n\n \u003Cdiv class=\u0022flex justify-between space-x-4 items-center\u0022\u003E\n \u003Ca href=\u0022\/fr\/label\/investnet\u0022\n title=\u0022 InvestNet\n\u0022\n class=\u0022transition-colors bg-white hover:bg-opacity-50 hover:bg-brand-light rounded-md hover:border-solid hover:border-gray-50 -mx-2 w-full min-w-0\u0022\u003E\n \u003Cdiv class=\u0022flex space-x-4 p-2\u0022\u003E\n \u003Cdiv class=\u0022flex-shrink-0 h-10 w-10 max-w-full profile\u0022\u003E\n \u003Cimg loading=\u0022lazy\u0022 src=\u0022https:\/\/dr84voq2lwxr8.cloudfront.net\/s3fs-public\/styles\/social_medium\/public\/legacy\/58\/ea491211-investnet_0.png?VersionId=Tt0n7JhV5errOBvHlitjjylDzlTl2xnx\u0026amp;itok=hUPgNB-G\u0022 width=\u002244\u0022 height=\u002244\u0022 alt=\u0022Logo\u0022 class=\u0022image-style-social-medium\u0022 \/\u003E\n\n\n\n\n \u003C\/div\u003E\n \u003Cdiv class=\u0022flex-1 overflow-hidden\u0022\u003E\n \u003Cdiv class=\u0022text-sm font-bold text-content-dark truncate\u0022\u003E\n InvestNet\n\n \u003C\/div\u003E\n \u003Cdiv class=\u0022text-sm text-content-dark truncate\u0022\u003E\n \n \u003C\/div\u003E\n \u003Cdiv class=\u0022text-sm text-content-dark truncate\u0022\u003E\n \u003Cp class=\u0022flex items-center space-x-1\u0022\u003E\n \u003Cspan class=\u0022text-content\u0022\u003E\u003Cem class=\u0022placeholder\u0022\u003E2182\u003C\/em\u003E organisations labellis\u00e9es\u003C\/span\u003E\n \u003C\/p\u003E\n\n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/a\u003E\n \u003C\/div\u003E\n\n\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n\u003C\/div\u003E\n\u003Cdiv class=\u0022card px-4 md:px-8 py-5 md:py-6 js-accordion overflow-visible\u0022\u003E\n \u003Cdiv\u003E\n \u003Cheader class=\u0022mb-3\u0022\u003E\n \u003Ch3 class=\u0022h5\u0022\u003E\n \u003Cbutton aria-expanded=\u0022false\u0022\n aria-controls=\u0022\u0022\n class=\u0022w-full text-left flex items-center mb-3 h5\u0022\n \u003E\n \u003Cspan class=\u0022flex-1 text-content-light\u0022\u003E\n \u00c9quipe (8)\n \u003C\/span\u003E\n \u003Cspan class=\u0022transform rotate-90\u0022\u003E\n \n\u003Csvg viewBox=\u00220 0 24 24\u0022\n class=\u0022w-5 h-5 \u0022\n role=\u0022img\u0022\n aria-label=\u0022arrow_forward\u0022\n focusable=\u0022false\u0022\u003E\n \u003Cuse xlink:href=\u0022#symbol-arrow_forward\u0022\u003E\u003C\/use\u003E\n\u003C\/svg\u003E\n \u003C\/span\u003E\n \u003C\/button\u003E\n \u003C\/h3\u003E\n \u003C\/header\u003E\n \u003Cdiv class=\u0022divide-y relative\u0022\u003E\n \n\u003Cdiv class=\u0022flex justify-between space-x-4 items-center\u0022\u003E\n \u003Ca href=\u0022\/fr\/profile\/78592\u0022\n title=\u0022Alex TEST\u0022\n class=\u0022transition-colors bg-white hover:bg-opacity-50 hover:bg-brand-light rounded-md hover:border-solid hover:border-gray-50 -mx-2 w-full min-w-0\u0022\u003E\n \u003Cdiv class=\u0022flex space-x-4 p-2\u0022\u003E\n \u003Cdiv class=\u0022flex-shrink-0 h-10 w-10 max-w-full profile\u0022\u003E\n \n\n\u003Cdiv class=\u0022aspect-w-1 aspect-h-1\u0022\u003E\n \u003Cimg class=\u0022avatar \u0022\n src=\u0022\/themes\/custom\/bpi_theme_euroquity\/assets\/images\/fallback\/avatar-profile.png\u0022\n loading=\u0022lazy\u0022\n alt=\u0022Avatar\u0022 \/\u003E\n\u003C\/div\u003E\n \u003C\/div\u003E\n \u003Cdiv class=\u0022flex-1 overflow-hidden\u0022\u003E\n \u003Cdiv class=\u0022text-sm font-bold text-content-dark truncate\u0022\u003E\n Alex\n TEST\n\n \u003C\/div\u003E\n \u003Cdiv class=\u0022text-sm text-content-dark truncate\u0022\u003E\n \n \u003C\/div\u003E\n \u003Cdiv class=\u0022text-sm text-content-dark truncate\u0022\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/a\u003E\n \u003C\/div\u003E\n\n \n\u003Cdiv class=\u0022flex justify-between space-x-4 items-center\u0022\u003E\n \u003Ca href=\u0022\/fr\/profile\/44593\u0022\n title=\u0022Louis-Marie Bachelot\u0022\n class=\u0022transition-colors bg-white hover:bg-opacity-50 hover:bg-brand-light rounded-md hover:border-solid hover:border-gray-50 -mx-2 w-full min-w-0\u0022\u003E\n \u003Cdiv class=\u0022flex space-x-4 p-2\u0022\u003E\n \u003Cdiv class=\u0022flex-shrink-0 h-10 w-10 max-w-full profile\u0022\u003E\n \u003Cimg loading=\u0022lazy\u0022 src=\u0022https:\/\/dr84voq2lwxr8.cloudfront.net\/s3fs-public\/styles\/social_medium\/public\/legacy\/485\/ace651d4-photo-reseaux-sociaux_0.jpg?VersionId=VjaAqehDeVD8Sa2OVWWkbYQGqlLeLcms\u0026amp;itok=oILBrWuF\u0022 width=\u002244\u0022 height=\u002244\u0022 alt=\u0022Profile photo\u0022 class=\u0022image-style-social-medium\u0022 \/\u003E\n\n\n\n\n \u003C\/div\u003E\n \u003Cdiv class=\u0022flex-1 overflow-hidden\u0022\u003E\n \u003Cdiv class=\u0022text-sm font-bold text-content-dark truncate\u0022\u003E\n Louis-Marie\n Bachelot\n\n \u003C\/div\u003E\n \u003Cdiv class=\u0022text-sm text-content-dark truncate\u0022\u003E\n \n \u003C\/div\u003E\n \u003Cdiv class=\u0022text-sm text-content-dark truncate\u0022\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/a\u003E\n \u003C\/div\u003E\n\n \n\u003Cdiv class=\u0022flex justify-between space-x-4 items-center\u0022\u003E\n \u003Ca href=\u0022\/fr\/profile\/44759\u0022\n title=\u0022Claire L\u00e9pinoux-Chambaud\u0022\n class=\u0022transition-colors bg-white hover:bg-opacity-50 hover:bg-brand-light rounded-md hover:border-solid hover:border-gray-50 -mx-2 w-full min-w-0\u0022\u003E\n \u003Cdiv class=\u0022flex space-x-4 p-2\u0022\u003E\n \u003Cdiv class=\u0022flex-shrink-0 h-10 w-10 max-w-full profile\u0022\u003E\n \u003Cimg loading=\u0022lazy\u0022 src=\u0022https:\/\/dr84voq2lwxr8.cloudfront.net\/s3fs-public\/styles\/social_medium\/public\/legacy\/500\/900df596-aaeaaqaaaaaaaac8aaaajdfjmzcwztg0ltewmmqtnge5os04ngi5ltg5nde2n2q0zwe1nq_0.jpg?VersionId=gPfK1GPnEVN4DJrs8ufzfSpfBEWsXbyV\u0026amp;itok=Y9TuPRUj\u0022 width=\u002244\u0022 height=\u002244\u0022 alt=\u0022Profile photo\u0022 class=\u0022image-style-social-medium\u0022 \/\u003E\n\n\n\n\n \u003C\/div\u003E\n \u003Cdiv class=\u0022flex-1 overflow-hidden\u0022\u003E\n \u003Cdiv class=\u0022text-sm font-bold text-content-dark truncate\u0022\u003E\n Claire\n L\u00e9pinoux-Chambaud\n\n \u003C\/div\u003E\n \u003Cdiv class=\u0022text-sm text-content-dark truncate\u0022\u003E\n \n \u003C\/div\u003E\n \u003Cdiv class=\u0022text-sm text-content-dark truncate\u0022\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/div\u003E\n \u003C\/a\u003E\n \u003C\/div\u003E\n\n \u003C\/div\u003E\n \u003Cdiv role=\u0022region\u0022 aria-hidden=\u0022true\u0022\u003E\n \u003Cdiv class=\u0022js-group-admins-secondary divide-y border-t\u0022\u003E\n \u003C\/div\u003E\n \n \u003C\/div\u003E\n \u003C\/div\u003E\n\u003C\/div\u003E\n\u003Cdiv class=\u0022card mt-16 md:mt-20 px-4 py-5 md:p-8\u0022\u003E\n \u003Cheader class=\u0022mb-3\u0022\u003E\n \u003Ch2 class=\u0022h3\u0022\u003E\n Activit\u00e9 r\u00e9cente\n \u003C\/h2\u003E\n \u003C\/header\u003E\n \u003Cdiv class=\u0022rich-text\u0022\u003E\n \u003Carticle class=\u0022bg-yellow-50 card lazyloaded md:p-8 p-5 space-y-4\u0022\u003E\n \u003Cheader class=\u0022flex flex-row items-center\u0022\u003E\n \u003Cp class=\u0022font-bold text-xl flex-1 text-negative-600\u0022\u003E\n Vous n\u0027\u00eates pas connect\u00e9(e)\n \u003C\/p\u003E\n \u003C\/header\u003E\n \u003Cdiv class=\u0022text-negative-600 flex flex-col space-y-4\u0022\u003E\n \u003Cp\u003E\n Un certain nombre de contenus vous sont cach\u00e9s et vous ne b\u00e9n\u00e9ficiez pas des fonctionnalit\u00e9s de mises en relation.\n \u003C\/p\u003E\n \u003Cp\u003E\n \u003Cspan class=\u0022link font-semibold\u0022\u003E\u003Ca href=\u0022\/fr\/user\/sso-redirect\/login\u0022\u003ELog in\u003C\/a\u003E\u003C\/span\u003E or \u003Cspan class=\u0022link font-semibold\u0022\u003E\u003Ca href=\u0022\/fr\/user\/sso-redirect\/register\u0022\u003Eregister\u003C\/a\u003E\u003C\/span\u003E\n pour acc\u00e9der \u00e0 l\u2019int\u00e9gralit\u00e9 des contenus et fonctionnalit\u00e9s d\u2019EuroQuity : l\u2019inscription est rapide et gratuite !\n \u003C\/p\u003E\n \u003C\/div\u003E\n\u003C\/article\u003E\n\n \u003C\/div\u003E\n\u003C\/div\u003E\n\n \u003C\/div\u003E\n \u003C\/div\u003E\n\n","settings":null}]